Molecular Mechanisms of Biologically Active Compounds from Propolis in Breast Cancer: State of the Art and Future Directions

References

• Ferlay, J.; Colombet, M.; Soerjomataram, I.; Mathers, C.; Parkin, D. M.; Pineros, M.; Znaor, A.; Bray, F. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int. J. Cancer. 2019, 144(8), 1941–1953. DOI: 10.1002/ijc.31937.
   PubMed Web of Science ®Google Scholar
• Smith, R. A.; Andrews, K. S.; Brooks, D.; Fedewa, S. A.; Manassaram-Baptiste, D.; Saslow, D.; Wender, R. C. Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J. Clin. 2019, 69(3), 184–210. DOI: 10.3322/caac.21557.
   PubMed Web of Science ®Google Scholar
• Siegel, R. L.; Miller, K. D.; Jemal, A. Cancer statistics,2020. CA Cancer J. Clin. 2020, 70(1), 7–30. DOI: 10.3322/caac.21590.
   PubMed Web of Science ®Google Scholar
• Wesolowski, R.; Ramaswamy, B. Gene expression profiling: changing face of breast cancer classification and management. Gene Expr. 2011, 15(3), 105–115. DOI: 10.3727/105221611X13176664479241.
   PubMed Web of Science ®Google Scholar
• Polyak, K. Breast cancer: origins and evolution. J. Clin. Invest. 2007, 117(11), 3155–3163. DOI: 10.1172/JCI33295.
   PubMed Web of Science ®Google Scholar
• Pan, M. H.; Chiou, Y. S.; Chen, L. H.; Ho, C. T. Breast cancer chemoprevention by dietary natural phenolic compounds: specific epigenetic related molecular targets. Mol. Nutr. Food Res. 2015, 59(1), 21–35. DOI: 10.1002/mnfr.201400515.
   PubMed Web of Science ®Google Scholar
• Frion-Herrera, Y.; Diaz-Garcia, A.; Ruiz-Fuentes, J.; Rodriguez-Sanchez, H.; Sforcin, J. M. The cytotoxic effects of propolis on breast cancer cells involve PI3K/Akt and ERK1/2 pathways, mitochondrial membrane potential, and reactive oxygen species generation. Inflammopharmacology. 2019, 27(5), 1081–1089. DOI: 10.1007/s10787-018-0492-y.
   PubMed Web of Science ®Google Scholar
• Kang, G. Y.; Lee, E. R.; Kim, J. H.; Jung, J. W.; Lim, J.; Kim, S. K.; Cho, S. G.; Kim, K. P. Downregulation of PLK-1 expression in kaempferol-induced apoptosis of MCF-7 cells. Eur. J. Pharmacol. 2009, 611(1–3), 17–21. DOI: 10.1016/j.ejphar.2009.03.068.
   PubMed Web of Science ®Google Scholar
• Puranik, N. V.; Srivastava, P.; Bhatt, G.; John Mary, D. J. S.; Limaye, A. M.; Sivaraman, J. Determination and analysis of agonist and antagonist potential of naturally occurring flavonoids for estrogen receptor (ERalpha) by various parameters and molecular modelling approach. Sci. Rep. 2019, 9(1), 7450. DOI: 10.1038/s41598-019-43768-5.
   PubMedGoogle Scholar
• Jia, L.; Huang, S.; Yin, X.; Zan, Y.; Guo, Y.; Han, L. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction. Life Sci. 2018, 208, 123–130. DOI: 10.1016/j.lfs.2018.07.027.
   PubMed Web of Science ®Google Scholar
• Yang, B.; Huang, J.; Xiang, T.; Yin, X.; Luo, X.; Huang, J.; Luo, F.; Li, H.; Li, H.; Ren, G. Chrysin inhibits metastatic potential of human triple-negative breast cancer cells by modulating matrix metalloproteinase-10, epithelial to mesenchymal transition, and PI3K/Akt signaling pathway. J. Appl. Toxicol. 2014, 34(1), 105–112. DOI: 10.1002/jat.2941.
   PubMed Web of Science ®Google Scholar
• Watanabe, M. A.; Amarante, M. K.; Conti, B. J.; Sforcin, J. M. Cytotoxic constituents of propolis inducing anticancer effects: a review. J. Pharm. Pharmacol. 2011, 63(11), 1378–1386. DOI: 10.1111/j.2042-7158.2011.01331.x.
   PubMed Web of Science ®Google Scholar
• Li, X.; Zhou, N.; Wang, J.; Liu, Z.; Wang, X.; Zhang, Q.; Liu, Q.; Gao, L.; Wang, R. Quercetin suppresses breast cancer stem cells (CD44(+)/CD24(-)) by inhibiting the PI3K/Akt/mTOR-signaling pathway. Life Sci. 2018, 196, 56–62. DOI: 10.1016/j.lfs.2018.01.014.
   PubMed Web of Science ®Google Scholar
• Liu, D.; You, P.; Luo, Y.; Yang, M.; Liu, Y. Galangin Induces Apoptosis in MCF-7 Human Breast Cancer Cells Through Mitochondrial Pathway and Phosphatidylinositol 3-Kinase/Akt Inhibition. Pharmacology. 2018, 102(1–2), 58–66. DOI: 10.1159/000489564.
   PubMed Web of Science ®Google Scholar
• Wu, H. T.; Lin, J.; Liu, Y. E.; Chen, H. F.; Hsu, K. W.; Lin, S. H.; Peng, K. Y.; Lin, K. J.; Hsieh, C. C.; Chen, D. R. Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the AKT/mTOR signaling pathway. Phytomedicine. 2021, 81, 153437. DOI: 10.1016/j.phymed.2020.153437.
   PubMed Web of Science ®Google Scholar
• Kabala-Dzik, A.; Rzepecka-Stojko, A.; Kubina, R.; Jastrzebska-Stojko, Z.; Stojko, R.; Wojtyczka, R. D.; Stojko, J. Comparison of Two Components of Propolis: Caffeic Acid (CA) and Caffeic Acid Phenethyl Ester (CAPE) Induce Apoptosis and Cell Cycle Arrest of Breast Cancer Cells MDA-MB-231. Molecules. 2017, 22(9), 1554. DOI: 10.3390/molecules22091554.
   PubMed Web of Science ®Google Scholar
• Kabala-Dzik, A.; Rzepecka-Stojko, A.; Kubina, R.; Iriti, M.; Wojtyczka, R. D.; Buszman, E.; Stojko, J. Flavonoids, bioactive components of propolis, exhibit cytotoxic activity and induce cell cycle arrest and apoptosis in human breast cancer cells MDA-MB-231 and MCF-7 - a comparative study. Cell. Mol. Biol. (Noisy-le-grand). 2018, 64(8), 1–10. DOI: 10.14715/cmb/2018.64.8.1.
   PubMed Web of Science ®Google Scholar
• Tseng, T. H.; Chien, M. H.; Lin, W. L.; Wen, Y. C.; Chow, J. M.; Chen, C. K.; Kuo, T. C.; Lee, W. J. Inhibition of MDA-MB-231 breast cancer cell proliferation and tumor growth by apigenin through induction of G2/M arrest and histone H3 acetylation-mediated p21(WAF1/CIP1) expression. Environ. Toxicol. 2017, 32(2), 434–444. DOI: 10.1002/tox.22247.
   PubMed Web of Science ®Google Scholar
• Popolo, A.; Piccinelli, A. L.; Morello, S.; Sorrentino, R.; Osmany, C. R.; Rastrelli, L.; Pinto, A. Cytotoxic activity of nemorosone in human MCF-7 breast cancer cells. Can. J. Physiol. Pharmacol. 2011, 89(1), 50–57. DOI: 10.1139/Y10-100.
   PubMed Web of Science ®Google Scholar
• Assumpcao, J. H. M.; Takeda, A. A. S.; Sforcin, J. M.; Rainho, C. A. Effects of Propolis and Phenolic Acids on Triple-Negative Breast Cancer Cell Lines: Potential Involvement of Epigenetic Mechanisms. Molecules. 2020, 25(6), 1289. DOI: 10.3390/molecules25061289.
   PubMed Web of Science ®Google Scholar
• Dong, X.; Zhang, J.; Yang, F.; Wu, J.; Cai, R.; Wang, T.; Zhang, J. Effect of luteolin on the methylation status of the OPCML gene and cell growth in breast cancer cells. Exp. Ther. Med. 2018, 16(4), 3186–3194. DOI: 10.3892/etm.2018.6526.
   PubMed Web of Science ®Google Scholar
• Motawi, T. K.; Abdelazim, S. A.; Darwish, H. A.; Elbaz, E. M.; Shouman, S. A. Could Caffeic Acid Phenethyl Ester Expand the Antitumor Effect of Tamoxifen in Breast Carcinoma? Nutr. Cancer. 2016, 68(3), 435–445. DOI: 10.1080/01635581.2016.1153669.
   PubMed Web of Science ®Google Scholar
• Xu, Z.; Zhao, D.; Zheng, X.; Huang, B.; Xia, X.; Pan, X. Quercetin exerts bidirectional regulation effects on the efficacy of tamoxifen in estrogen receptor-positive breast cancer therapy: An in vitro study. Environ. Toxicol. 2020, 35(11), 1179–1193. DOI: 10.1002/tox.22983.
   PubMed Web of Science ®Google Scholar
• Kuropatnicki, A. K.; Szliszka, E.; Krol, W. Historical aspects of propolis research in modern times. Evid. Based Complement. Alternat. Med. 2013, 2013, 964149. DOI: 10.1155/2013/964149.
   PubMed Web of Science ®Google Scholar
• Medic-Saric, M.; Rastija, V.; Bojic, M.; Males, Z. From functional food to medicinal product: systematic approach in analysis of polyphenolics from propolis and wine. Nutr. J. 2009, 8(1), 33. DOI: 10.1186/1475-2891-8-33.
   PubMed Web of Science ®Google Scholar
• Bender, C.; Graziano, S. Evaluation of the antioxidant activity of foods in human cells. Nutrafoods. 2015, 14(2), 1–7. DOI: 10.1007/s13749-015-0016-y.
   Google Scholar
• Carreño, A. L.; Alday, E.; Quintero, J.; Pérez, L.; Valencia, D.; Robles-Zepeda, R.; Valdez-Ortega, J.; Hernandez, J.; Velazquez, C. Protective effect of Caffeic Acid Phenethyl Ester (CAPE) against oxidative stress. J. Funct. Foods. 2017, 29, 179–184. DOI: 10.1016/j.jff.2016.12.008.
   Web of Science ®Google Scholar
• Cornara, L.; Biagi, M.; Xiao, J.; Burlando, B. Therapeutic Properties of Bioactive Compounds from Different Honeybee Products. Front. Pharmacol. 2017, 8, 412. DOI: 10.3389/fphar.2017.00412.
   PubMed Web of Science ®Google Scholar
• Huang, S.; Zhang, C. P.; Wang, K.; Li, G. Q.; Hu, F. L. Recent advances in the chemical composition of propolis. Molecules. 2014, 19(12), 19610–19632. DOI: 10.3390/molecules191219610.
   PubMed Web of Science ®Google Scholar
• Sforcin, J. M. Biological Properties and The rapeutic Applications of Propolis. Phytother Res. 2016, 30(6), 894–905. DOI: 10.1002/ptr.5605.
   PubMed Web of Science ®Google Scholar
• Perou, C. M.; Sorlie, T.; Eisen, M. B.; van de Rijn, M.; Jeffrey, S. S.; Rees, C. A.; Pollack, J. R.; Ross, D. T.; Johnsen, H.; Akslen, L. A., et al. Molecular portraits of human breast tumours. Nature. 2000, 406(6797), 747–752.
   PubMed Web of Science ®Google Scholar
• Sorlie, T.; Perou, C. M.; Tibshirani, R.; Aas, T.; Geisler, S.; Johnsen, H.; Hastie, T.; Eisen, M. B.; van de Rijn, M.; Jeffrey, S. S., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(19), 10869–10874.
   PubMed Web of Science ®Google Scholar
• Loi, S.; Haibe-Kains, B.; Desmedt, C.; Lallemand, F.; Tutt, A. M.; Gillet, C.; Ellis, P.; Harris, A.; Bergh, J.; Foekens, J. A., et al. Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. J. Clin. Oncol. 2007, 25(10), 1239–1246.
   PubMed Web of Science ®Google Scholar
• Goldhirsch, A.; Wood, W. C.; Coates, A. S.; Gelber, R. D.; Thurlimann, B.; Senn, H. J.; Panel, M. Strategies for subtypes–dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann. Oncol. 2011, 22(8), 1736–1747. DOI: 10.1093/annonc/mdr304.
   PubMed Web of Science ®Google Scholar
• Voduc, K. D.; Cheang, M. C.; Tyldesley, S.; Gelmon, K.; Nielsen, T. O.; Kennecke, H. Breast cancer subtypes and the risk of local and regional relapse. J. Clin. Oncol. 2010, 28(10), 1684–1691. DOI: 10.1200/JCO.2009.24.9284.
   PubMed Web of Science ®Google Scholar
• Howlader, N.; Cronin, K. A.; Kurian, A. W.; Andridge, R. Differences in Breast Cancer Survival by Molecular Subtypes in the United States. Cancer Epidemiol. Biomarkers Prev. 2018, 27(6), 619–626. DOI: 10.1158/1055-9965.EPI-17-0627.
   PubMed Web of Science ®Google Scholar
• Hennigs, A.; Riedel, F.; Gondos, A.; Sinn, P.; Schirmacher, P.; Marme, F.; Jager, D.; Kauczor, H. U.; Stieber, A.; Lindel, K., et al. Prognosis of breast cancer molecular subtypes in routine clinical care: A large prospective cohort study. BMC cancer. 2016, 16(1), 734.
   PubMed Web of Science ®Google Scholar
• Harbeck, N.; Gnant, M. Breast cancer. Lancet. 2017, 389(10074), 1134–1150. DOI: 10.1016/S0140-6736(16)31891-8.
   PubMed Web of Science ®Google Scholar
• McDonald, E. S.; Clark, A. S.; Tchou, J.; Zhang, P.; Freedman, G. M. Clinical Diagnosis and Management of Breast Cancer. J. Nucl. Med. 2016, 57(Suppl 1), 9S–16S. DOI: 10.2967/jnumed.115.157834.
   PubMed Web of Science ®Google Scholar
• Hassan, M. S.; Ansari, J.; Spooner, D.; Hussain, S. A. Chemotherapy for breast cancer (Review). Oncol. Rep. 2010, 24(5), 1121–1131. DOI: 10.3892/or_00000963.
   PubMed Web of Science ®Google Scholar
• Tao, J. J.; Visvanathan, K.; Wolff, A. C. Long term side effects of adjuvant chemotherapy in patients with early breast cancer. Breast. 2015, 24(Suppl 2), S149–53. DOI: 10.1016/j.breast.2015.07.035.
   PubMed Web of Science ®Google Scholar
• Siegel, R. L.; Miller, K. D.; Jemal, A. Cancer statistics, 2019. CA Cancer J. Clin. 2019, 69(1), 7–34. DOI: 10.3322/caac.21551.
   PubMed Web of Science ®Google Scholar
• Harris, L.; Fritsche, H.; Mennel, R.; Norton, L.; Ravdin, P.; Taube, S.; Somerfield, M. R.; Hayes, D. F.; Bast, R. C., Jr. American Society of Clinical, O., American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J. Clin. Oncol. 2007, 25(33), 5287–5312. DOI: 10.1200/JCO.2007.14.2364.
   PubMed Web of Science ®Google Scholar
• Allred, D. C.; Carlson, R. W.; Berry, D. A.; Burstein, H. J.; Edge, S. B.; Goldstein, L. J.; Gown, A.; Hammond, M. E.; Iglehart, J. D.; Moench, S., et al. NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry. J Natl Compr Canc Netw. 2009, 7(Suppl 6), S1–S21. quiz S22-3, doi:10.6004/jnccn.2009.0079.
   PubMedGoogle Scholar
• Dowsett, M.; Nielsen, T. O.; A’Hern, R.; Bartlett, J.; Coombes, R. C.; Cuzick, J.; Ellis, M.; Henry, N. L.; Hugh, J. C.; Lively, T., et al. Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. J. Natl. Cancer Inst. 2011, 103(22), 1656–1664.
   PubMed Web of Science ®Google Scholar
• Harris, L. N.; Ismaila, N.; McShane, L. M.; Hayes, D. F. Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Summary. J Oncol Pract. 2016, 12(4), 384–389. DOI: 10.1200/JOP.2016.010868.
   PubMed Web of Science ®Google Scholar
• El Hachem, G.; Gombos, A.; Awada, A. Recent advances in understanding breast cancer and emerging therapies with a focus on luminal and triple-negative breast cancer. F1000Res. 2019, 8, 591. DOI: 10.12688/f1000research.17542.1.
   Google Scholar
• Porta, C.; Paglino, C.; Mosca, A. Targeting PI3K/Akt/mTOR Signaling in Cancer. Front. Oncol. 2014, 4, 64. DOI: 10.3389/fonc.2014.00064.
   PubMedGoogle Scholar
• Presti, D.; Quaquarini, E. The PI3K/AKT/mTOR and CDK4/6 Pathways in Endocrine Resistant HR+/HER2- Metastatic Breast Cancer: Biological Mechanisms and New Treatments. Cancers (Basel). 2019, 11(9), 1242. DOI: 10.3390/cancers11091242.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J.; Beach, D.; Shapiro, G. I. Targeting CDK4 and CDK6: From Discovery to Therapy. Cancer Discov. 2016, 6(4), 353–367. DOI: 10.1158/2159-8290.CD-15-0894.
   PubMed Web of Science ®Google Scholar
• Dent, R.; Trudeau, M.; Pritchard, K. I.; Hanna, W. M.; Kahn, H. K.; Sawka, C. A.; Lickley, L. A.; Rawlinson, E.; Sun, P.; Narod, S. A. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin. Cancer Res. 2007, 13(15 Pt 1), 4429–4434. DOI: 10.1158/1078-0432.CCR-06-3045.
   PubMed Web of Science ®Google Scholar
• DeSantis, C. E.; Ma, J.; Gaudet, M. M.; Newman, L. A.; Miller, K. D.; Goding Sauer, A.; Jemal, A.; Siegel, R. L. Breast cancer statistics, 2019. CA Cancer J. Clin. 2019, 69(6), 438–451. DOI: 10.3322/caac.21583.
   PubMed Web of Science ®Google Scholar
• Azim, H. A.; Ghosn, M.; Oualla, K.; Kassem, L. Personalized treatment in metastatic triple-negative breast cancer: The outlook in 2020. Breast J. 2019.
   Web of Science ®Google Scholar
• Lyons, T. G. Targeted Therapies for Triple-Negative Breast Cancer. Curr Treat Options Oncol. 2019, 20(11), 82. DOI: 10.1007/s11864-019-0682-x.
   PubMed Web of Science ®Google Scholar
• McCann, K. E.; Hurvitz, S. A.; McAndrew, N. Advances in Targeted Therapies for Triple-Negative Breast Cancer. Drugs. 2019, 79(11), 1217–1230. DOI: 10.1007/s40265-019-01155-4.
   PubMed Web of Science ®Google Scholar
• Bankova, V. Recent trends and important developments in propolis research. Evid. Based Complement. Alternat. Med. 2005, 2(1), 29–32. DOI: 10.1093/ecam/neh059.
   PubMed Web of Science ®Google Scholar
• Simone-Finstrom, M.; Spivak, M. Propolis and bee health: the natural history and significance of resin use by honey bees. Apidologie. 2010, 41(3), 295–311. DOI: 10.1051/apido/2010016.
   Web of Science ®Google Scholar
• Bankova, V.; Bertelli, D.; Borba, R.; Conti, B. J.; Da Silva Cunha, I. B.; Danert, C.; Nogueira Eberlin, M.; Falcão, S. I.; Isla, M. I.; Nieva Moreno, M. I., et al. Standard methods for Apis mellifera propolis research. J. Apic. Res. 2016, 58(2), 1–49.
   Google Scholar
• Bankova, V. Chemical diversity of propolis and the problem of standardization. J. Ethnopharmacol. 2005, 100(1–2), 114–117. DOI: 10.1016/j.jep.2005.05.004.
   PubMed Web of Science ®Google Scholar
• Blicharska, N.; Seidel, V. Chemical Diversity and Biological Activity of African Propolis. Prog Chem Org Nat Prod. 2019, 109, 415–450. DOI: 10.1007/978-3-030-12858-6_3.
   PubMedGoogle Scholar
• Cuesta-Rubio, O.; Piccinelli, A. L.; Rastrelli, L. Tropical propolis: advances in chemical components and botanical origin. Med. Plants. 2012, 209–240.
   Google Scholar
• Alday, E.; Navarro-Navarro, M.; Garibay-Escobar, A.; Robles-Zepeda, R.; Hernandez, J.; Velazquez, C. Advances in Pharmacological Activities and Chemical Composition of Propolis Produced in Americas. In Beekeeping and Bee Conservation - Advances in Research; InTech, 2016; pp 99–151.
   Google Scholar
• Ozdal, T.; Sari-Kaplan, G.; Mutlu-Altundag, E.; Boyacioglu, D.; Capanoglu, E. Evaluation of Turkish propolis for its chemical composition, antioxidant capacity, anti-proliferative effect on several human breast cancer cell lines and proliferative effect on fibroblasts and mouse mesenchymal stem cell line. J. Apic. Res. 2018, 57(5), 627–638. DOI: 10.1080/00218839.2018.1494888.
   Web of Science ®Google Scholar
• Popova, M.; Trusheva, B.; Khismatullin, R.; Gavrilova, N.; Legotkina, G.; Lyapunov, J.; Bankova, V. The triple botanical origin of Russian propolis from the Perm Region, its phenolic content and antimicrobial activity. Nat. prod. communicat. 2013, 8(5), 617–620. DOI: 10.1177/1934578X1300800519.
   Web of Science ®Google Scholar
• Bankova, V.; Boudourova-Krasteva, G.; Sforcin, J. M.; Frete, X.; Kujumgiev, A.; Maimoni-Rodella, R.; Popov, S. Phytochemical evidence for the plant origin of Brazilian propolis from Sao Paulo state. Z Naturforsch C J Biosci. 1999, 54(5–6), 401–405. DOI: 10.1515/znc-1999-5-616.
   PubMedGoogle Scholar
• Cuesta-Rubio, O.; Velez-Castro, H.; Frontana-Uribe, B. A.; Cardenas, J. Nemorosone, the major constituent of floral resins of Clusia rosea. Phytochemistry. 2001, 57(2), 279–283. DOI: 10.1016/S0031-9422(00)00510-0.
   PubMed Web of Science ®Google Scholar
• Cuesta-Rubio, O.; Frontana-Uribe, B. A.; Ramirez-Apan, T.; Cardenas, J. Polyisoprenylated benzophenones in cuban propolis; biological activity of nemorosone. Z Naturforsch C J Biosci. 2002, 57(3–4), 372–378. DOI: 10.1515/znc-2002-3-429.
   PubMed Web of Science ®Google Scholar
• Cuesta-Rubio, O.; Piccinelli, A. L.; Fernandez, M. C.; Hernandez, I. M.; Rosado, A.; Rastrelli, L. Chemical characterization of Cuban propolis by HPLC-PDA, HPLC-MS, and NMR: the brown, red, and yellow Cuban varieties of propolis. J. Agric. Food Chem. 2007, 55(18), 7502–7509. DOI: 10.1021/jf071296w.
   PubMed Web of Science ®Google Scholar
• Hernandez, I. M.; Fernandez, M. C.; Cuesta-Rubio, O.; Piccinelli, A. L.; Rastrelli, L. Polyprenylated benzophenone derivatives from Cuban propolis. J. Nat. Prod. 2005, 68(6), 931–934. DOI: 10.1021/np0495884.
   PubMed Web of Science ®Google Scholar
• Trusheva, B.; Popova, M.; Naydenski, H.; Tsvetkova, I.; Gregorio Rodriguez, J.; Bankova, V. New polyisoprenylated benzophenones from Venezuelan propolis. Fitoterapia. 2004, 75(7–8), 683–689. DOI: 10.1016/j.fitote.2004.08.001.
   PubMed Web of Science ®Google Scholar
• Trusheva, B.; Popova, M.; Bankova, V.; Simova, S.; Marcucci, M. C.; Miorin, P. L.; Da Rocha Pasin, F.; Tsvetkova, I. Bioactive constituents of brazilian red propolis. Evid. Based Complement. Alternat. Med. 2006, 3(2), 249–254. DOI: 10.1093/ecam/nel006.
   PubMed Web of Science ®Google Scholar
• Alencar, S. M.; Oldoni, T. L.; Castro, M. L.; Cabral, I. S.; Costa-Neto, C. M.; Cury, J. A.; Rosalen, P. L.; Ikegaki, M. Chemical composition and biological activity of a new type of Brazilian propolis: red propolis. J. Ethnopharmacol. 2007, 113(2), 278–283. DOI: 10.1016/j.jep.2007.06.005.
   PubMed Web of Science ®Google Scholar
• Lotti, C.; Campo Fernandez, M.; Piccinelli, A. L.; Cuesta-Rubio, O.; Marquez Hernandez, I.; Rastrelli, L. Chemical constituents of red Mexican propolis. J. Agric. Food Chem. 2010, 58(4), 2209–2213. DOI: 10.1021/jf100070w.
   PubMed Web of Science ®Google Scholar
• Piccinelli, A. L.; Campo Fernandez, M.; Cuesta-Rubio, O.; Marquez Hernandez, I.; De Simone, F.; Rastrelli, L. Isoflavonoids isolated from Cuban propolis. J. Agric. Food Chem. 2005, 53(23), 9010–9016. DOI: 10.1021/jf0518756.
   PubMed Web of Science ®Google Scholar
• Kamiya, T.; Nishihara, H.; Hara, H.; Adachi, T. Ethanol extract of Brazilian red propolis induces apoptosis in human breast cancer MCF-7 cells through endoplasmic reticulum stress. J. Agric. Food Chem. 2012, 60(44), 11065–11070. DOI: 10.1021/jf303004n.
   PubMed Web of Science ®Google Scholar
• Popova, M. P.; Graikou, K.; Chinou, I.; Bankova, V. S. GC-MS profiling of diterpene compounds in Mediterranean propolis from Greece. J. Agric. Food Chem. 2010, 58(5), 3167–3176. DOI: 10.1021/jf903841k.
   PubMed Web of Science ®Google Scholar
• Popova, M.; Trusheva, B.; Cutajar, S.; Antonova, D.; Mifsud, D.; Farrugia, C.; Bankova, V. Identification of the plant origin of the botanical biomarkers of Mediterranean type propolis. Nat. Prod. Commun. 2012, 7(5), 569–570.
   PubMed Web of Science ®Google Scholar
• Graikou, K.; Popova, M.; Gortzi, O.; Bankova, V.; Chinou, I. Characterization and biological evaluation of selected Mediterranean propolis samples. Is it a new type? LWT - Food Sci. Technol. 2016, 65, 261–267. DOI: 10.1016/j.lwt.2015.08.025.
   Web of Science ®Google Scholar
• El-Guendouz, S.; Lyoussi, B.; Miguel, M. G. Insight on Propolis from Mediterranean Countries: Chemical Composition, Biological Activities and Application Fields. Chem. Biodivers. 2019, 16(7), e1900094. DOI: 10.1002/cbdv.201900094.
   PubMed Web of Science ®Google Scholar
• Kumazawa, S.; Nakamura, J.; Murase, M.; Miyagawa, M.; Ahn, M. R.; Fukumoto, S. Plant origin of Okinawan propolis: honeybee behavior observation and phytochemical analysis. Naturwissenschaften. 2008, 95(8), 781–786. DOI: 10.1007/s00114-008-0383-y.
   PubMedGoogle Scholar
• Trusheva, B.; Popova, M.; Koendhori, E. B.; Tsvetkova, I.; Naydenski, C.; Bankova, V. Indonesian propolis: chemical composition, biological activity and botanical origin. Nat. Prod. Res. 2011, 25(6), 606–613. DOI: 10.1080/14786419.2010.488235.
   PubMed Web of Science ®Google Scholar
• Kardar, M. N.; Zhang, T.; Coxon, G. D.; Watson, D. G.; Fearnley, J.; Seidel, V. Characterisation of triterpenes and new phenolic lipids in Cameroonian propolis. Phytochemistry. 2014, 106, 156–163. DOI: 10.1016/j.phytochem.2014.07.016.
   PubMed Web of Science ®Google Scholar
• Zhang, T.; Omar, R.; Siheri, W.; Al Mutairi, S.; Clements, C.; Fearnley, J.; Edrada-Ebel, R.; Watson, D. Chromatographic analysis with different detectors in the chemical characterisation and dereplication of African propolis. Talanta. 2014, 120, 181–190. DOI: 10.1016/j.talanta.2013.11.094.
   PubMed Web of Science ®Google Scholar
• Ngenge, T.; Carol, D.; Emmanuel, T.; Vernyuy, T.; Joseph, M.; Popova, M.; Bankova, V. Chemical constituents and anti-ulcer activity of propolis from the North-West region of Cameroon. Res. J. Phytochemistry. 2016, 10(2), 45–57. DOI: 10.3923/rjphyto.2016.45.57.
   Google Scholar
• Burdock, G. A. Review of the biological properties and toxicity of bee propolis (propolis). Food Chem. Toxicol. 1998, 36(4), 347–363. DOI: 10.1016/S0278-6915(97)00145-2.
   PubMed Web of Science ®Google Scholar
• Sforcin, J. M.; Bankova, V. Propolis: is there a potential for the development of new drugs? J. Ethnopharmacol. 2011, 133(2), 253–260. DOI: 10.1016/j.jep.2010.10.032.
   PubMed Web of Science ®Google Scholar
• Braakhuis, A. Evidence on the Health Benefits of Supplemental Propolis. Nutrients. 2019, 11(11), 2705. DOI: 10.3390/nu11112705.
   PubMed Web of Science ®Google Scholar
• Silva-Carvalho, R.; Baltazar, F.; Almeida-Aguiar, C. Propolis: A Complex Natural Product with a Plethora of Biological Activities That Can Be Explored for Drug Development. Evid. Based Complement. Alternat. Med. 2015, 2015, 206439. DOI: 10.1155/2015/206439.
   PubMed Web of Science ®Google Scholar
• Robles-Zepeda, R. E.; Martínez, J. H.; Garibay Escobar, A.; Valencia Rivera, D. E.; Velazquez-Contreras, C. A. Botanical Origin and Biological Activity of Propolis. Med. Plants, Biodiversity Drugs. 2012.
   Google Scholar
• Sawicka, D.; Car, H.; Borawska, M. H.; Niklinski, J. The anticancer activity of propolis. Folia Histochem. Cytobiol. 2012, 50(1), 25–37. DOI: 10.5603/FHC.2012.0004.
   PubMed Web of Science ®Google Scholar
• Georgieva, K.; Trusheva, B.; Uzunova, V.; Stoyanova, T.; Valcheva, V.; Popova, M.; Tzoneva, R.; Bankova, V. New cycloartane triterpenes from bioactive extract of propolis from Pitcairn Island. Fitoterapia. 2018, 128, 233–241. DOI: 10.1016/j.fitote.2018.05.024.
   PubMed Web of Science ®Google Scholar
• Thirugnanasampandan, R.; Raveendran, S. B.; Jayakumar, R. Analysis of chemical composition and bioactive property evaluation of Indian propolis. Asian Pac. J. Trop. Biomed. 2012, 2(8), 651–654. DOI: 10.1016/S2221-1691(12)60114-2.
   PubMedGoogle Scholar
• Rzepecka-Stojko, A.; Kabala-Dzik, A.; Mozdzierz, A.; Kubina, R.; Wojtyczka, R. D.; Stojko, R.; Dziedzic, A.; Jastrzebska-Stojko, Z.; Jurzak, M.; Buszman, E., et al. Caffeic Acid phenethyl ester and ethanol extract of propolis induce the complementary cytotoxic effect on triple-negative breast cancer cell lines. Molecules. 2015, 20(5), 9242–9262.
   PubMed Web of Science ®Google Scholar
• Badria, F.; Fathy, H.; Fatehe, A.; Elimam, D.; Ghazy, M. Evaluate the cytotoxic activity of honey, propolis, and bee venom from different localities in Egypt against liver, breast, and colorectal cancer. J. Apither. 2017, 2(1), 1–4. DOI: 10.5455/ja.20170203075953.
   Google Scholar
• Hernandez, J.; Goycoolea, F. M.; Quintero, J.; Acosta, A.; Castaneda, M.; Dominguez, Z.; Robles, R.; Vazquez-Moreno, L.; Velazquez, E. F.; Astiazaran, H., et al. Sonoran propolis: chemical composition and antiproliferative activity on cancer cell lines. Planta Med. 2007, 73(14), 1469–1474.
   PubMed Web of Science ®Google Scholar
• Valencia, D.; Alday, E.; Robles-Zepeda, R.; Garibay-Escobar, A.; Galvez-Ruiz, J. C.; Salas-Reyes, M.; Jiménez-Estrada, M.; Velazquez-Contreras, E.; Hernandez, J.; Velazquez, C. Seasonal effect on chemical composition and biological activities of Sonoran propolis. Food Chem. 2012, 131(2), 645–651. DOI: 10.1016/j.foodchem.2011.08.086.
   Web of Science ®Google Scholar
• Xuan, H.; Li, Z.; Yan, H.; Sang, Q.; Wang, K.; He, Q.; Wang, Y.; Hu, F. Antitumor Activity of Chinese Propolis in Human Breast Cancer MCF-7 and MDA-MB-231 Cells. Evid. Based Complement. Alternat. Med. 2014, 2014, 280120. DOI: 10.1155/2014/280120.
   PubMed Web of Science ®Google Scholar
• Misir, S.; Aliyazicioglu, Y.; Demir, S.; Turan, I.; Hepokur, C. Effect of Turkish Propolis on miRNA Expression, Cell Cycle, and Apoptosis in Human Breast Cancer (MCF-7) Cells. Nutr. Cancer. 2020, 72(1), 133–145. DOI: 10.1080/01635581.2019.1616100.
   PubMed Web of Science ®Google Scholar
• Inoue, K.; Saito, M.; Kanai, T.; Kawata, T.; Shigematsu, N.; Uno, T.; Isobe, K.; Liu, C.-H.; Ito, H. Anti-tumor effects of water-soluble propolis on a mouse sarcoma cell line in vivo and in vitro. Am. J. Chin. Med. 2008, 36, 625–634. DOI: 10.1142/S0192415X0800603X.
   PubMed Web of Science ®Google Scholar
• Seyhan, M. F.; Yilmaz, E.; Timirci-Kahraman, O.; Saygili, N.; Kisakesen, H. I.; Gazioglu, S.; Goren, A. C.; Eronat, A. P.; Begum Ceviz, A.; Ozturk, T., et al. Different propolis samples, phenolic content, and breast cancer cell lines: Variable cytotoxicity ranging from ineffective to potent. IUBMB life. 2019, 71(5), 619–631.
   PubMed Web of Science ®Google Scholar
• Popolo, A.; Piccinelli, L. A.; Morello, S.; Cuesta-Rubio, O.; Sorrentino, R.; Rastrelli, L.; Pinto, A. Antiproliferative activity of brown Cuban propolis extract on human breast cancer cells. Nat. Prod. Commun. 2009, 4(12), 1711–1716.
   PubMed Web of Science ®Google Scholar
• Noureddine, H.; Hage-Sleiman, R.; Wehbi, B.; Fayyad-Kazan, H.; Hayar, S.; Traboulssi, M.; Alyamani, O. A.; Faour, W. H.; ElMakhour, Y. Chemical characterization and cytotoxic activity evaluation of Lebanese propolis. Biomed. Pharmacother. 2017, 95, 298–307. DOI: 10.1016/j.biopha.2017.08.067.
   PubMed Web of Science ®Google Scholar
• Conti, B. J.; Santiago, K. B.; Bufalo, M. C.; Herrera, Y. F.; Alday, E.; Velazquez, C.; Hernandez, J.; Sforcin, J. M. Modulatory effects of propolis samples from Latin America (Brazil, Cuba and Mexico) on cytokine production by human monocytes. J. Pharm. Pharmacol. 2015, 67(10), 1431–1438. DOI: 10.1111/jphp.12431.
   PubMed Web of Science ®Google Scholar
• Karimian, A.; Ahmadi, Y.; Yousefi, B. Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage. DNA Repair (Amst). 2016, 42, 63–71. DOI: 10.1016/j.dnarep.2016.04.008.
   PubMed Web of Science ®Google Scholar
• Abbastabar, M.; Kheyrollah, M.; Azizian, K.; Bagherlou, N.; Tehrani, S. S.; Maniati, M.; Karimian, A. Multiple functions of p27 in cell cycle, apoptosis, epigenetic modification and transcriptional regulation for the control of cell growth: A double-edged sword protein. DNA Repair (Amst). 2018, 69, 63–72. DOI: 10.1016/j.dnarep.2018.07.008.
   PubMed Web of Science ®Google Scholar
• Hafner, A.; Bulyk, M. L.; Jambhekar, A.; Lahav, G. The multiple mechanisms that regulate p53 activity and cell fate. Nat. Rev. Mol. Cell Biol. 2019, 20(4), 199–210. DOI: 10.1038/s41580-019-0110-x.
   PubMed Web of Science ®Google Scholar
• Tartik, M.; Darendelioglu, E.; Aykutoglu, G.; Baydas, G. Turkish propolis supresses MCF-7 cell death induced by homocysteine. Biomed. Pharmacother. 2016, 82, 704–712. DOI: 10.1016/j.biopha.2016.06.013.
   PubMed Web of Science ®Google Scholar
• Zingue, S.; Cisilotto, J.; Fogang, R. C. M.; Tchoupang, E. N.; Ndinteh, D. T.; Tchuenguem Fohouo, N. F.; Njamen, D.; Creczynski-Pasa, T. B. The antimammary tumor effects of ethanolic extract of propolis from Adamawa region (Cameroon) are by apoptosis via reactive oxygen species-mediated mitochondrial pathway. Environ. Toxicol. 2021, 36(5), 861–873. DOI: 10.1002/tox.23089.
   PubMed Web of Science ®Google Scholar
• Chang, H.; Wang, Y.; Yin, X.; Liu, X.; Xuan, H. Ethanol extract of propolis and its constituent caffeic acid phenethyl ester inhibit breast cancer cells proliferation in inflammatory microenvironment by inhibiting TLR4 signal pathway and inducing apoptosis and autophagy. BMC Complement. Altern. Med. 2017, 17(1), 471. DOI: 10.1186/s12906-017-1984-9.
   PubMedGoogle Scholar
• Popova, M.; Trusheva, B.; Bankova, V. Propolis of stingless bees: A phytochemist’s guide through the jungle of tropical biodiversity. Phytomedicine. 2019, 153098. doi:10.1016/j.phymed.2019.153098.
   PubMed Web of Science ®Google Scholar
• Shanahan, M.; Spivak, M. Resin Use by Stingless Bees: A Review. Insects. 2021, 12(8), 719. DOI: 10.3390/insects12080719.
   PubMed Web of Science ®Google Scholar
• Amalia, E.; Diantini, A.; Subarnas, A. Water‑soluble propolis and bee pollen of Trigona spp from South Sulawesi Indonesia induce apoptosis in the human breast cancer MCF‑7 cell line. Oncol. Letters. 2020, 20(5), 1. DOI: 10.3892/ol.2020.12137.
   PubMed Web of Science ®Google Scholar
• Iqbal, M.; Fan, T. P.; Watson, D.; Alenezi, S.; Saleh, K.; Sahlan, M. Preliminary studies: The potential anti-angiogenic activities of two Sulawesi Island (Indonesia) propolis and their chemical characterization. Heliyon. 2019, 5(7), e01978. DOI: 10.1016/j.heliyon.2019.e01978.
   PubMed Web of Science ®Google Scholar
• Nugitrangson, P.; Puthong, S.; Iempridee, T.; Pimtong, W.; Pornpakakul, S.; Chanchao, C. In vitro and in vivo characterization of the anticancer activity of Thai stingless bee (Tetragonula laeviceps) cerumen. Experiment. Biol. Med. 2016, 241(2), 166–176. DOI: 10.1177/1535370215600102.
   PubMed Web of Science ®Google Scholar
• Kustiawan, P. M.; Phuwapraisirisan, P.; Puthong, S.; Palaga, T.; Arung, E. T.; Chanchao, C. Propolis from the Stingless Bee Trigona incisa from East Kalimantan, Indonesia, Induces In Vitro Cytotoxicity and Apoptosis in Cancer Cell lines. Asian Pac. J. Cancer Prev. 2015, 16(15), 6581–6589. DOI: 10.7314/APJCP.2015.16.15.6581.
   PubMedGoogle Scholar
• Kustiawan, P. M.; Puthong, S.; Arung, E. T.; Chanchao, C. In vitro cytotoxicity of Indonesian stingless bee products against human cancer cell lines. Asian Pac. J. Trop. Biomed. 2014, 4(7), 549–556. DOI: 10.12980/APJTB.4.2014APJTB-2013-0039.
   PubMedGoogle Scholar
• Choudhari, M. K.; Haghniaz, R.; Rajwade, J. M.; Paknikar, K. M. Anticancer activity of Indian stingless bee propolis: an in vitro study. Evid. Based Complement. Altern. Med. 2013, 2013.
   Web of Science ®Google Scholar
• Da Cunha, M. G.; Franchin, M.; Galvão, L.; de Ruiz, A.; de Carvalho, J. E.; Ikegaki, M.; de Alencar, S. M.; Koo, H.; Rosalen, P. L. Antimicrobial and antiproliferative activities of stingless bee Melipona scutellaris geopropolis. BMC Complementary Altern. Med. 2013, 13(1), 1–9. DOI: 10.1186/1472-6882-13-23.
   PubMedGoogle Scholar
• Umthong, S.; Phuwapraisirisan, P.; Puthong, S.; Chanchao, C. In vitro antiproliferative activity of partially purified Trigona laeviceps propolis from Thailand on human cancer cell lines. BMC Complementary Altern. Med. 2011, 11(1), 1–8. DOI: 10.1186/1472-6882-11-37.
   PubMedGoogle Scholar
• Imai, M.; Yokoe, H.; Tsubuki, M.; Takahashi, N. Growth Inhibition of Human Breast and Prostate Cancer Cells by Cinnamic Acid Derivatives and Their Mechanism of Action. Biol. Pharm. Bull. 2019, 42(7), 1134–1139. DOI: 10.1248/bpb.b18-01002.
   PubMed Web of Science ®Google Scholar
• Kabala-Dzik, A.; Rzepecka-Stojko, A.; Kubina, R.; Wojtyczka, R. D.; Buszman, E.; Stojko, J. Caffeic Acid Versus Caffeic Acid Phenethyl Ester in the Treatment of Breast Cancer MCF-7 Cells: Migration Rate Inhibition. Integr. Cancer Ther. 2018, 17(4), 1247–1259. DOI: 10.1177/1534735418801521.
   PubMed Web of Science ®Google Scholar
• Kabala-Dzik, A.; Rzepecka-Stojko, A.; Kubina, R.; Jastrzebska-Stojko, Z.; Stojko, R.; Wojtyczka, R. D.; Stojko, J. Migration Rate Inhibition of Breast Cancer Cells Treated by Caffeic Acid and Caffeic Acid Phenethyl Ester: An In Vitro Comparison Study. Nutrients. 2017, 9(10), 1144. DOI: 10.3390/nu9101144.
   PubMed Web of Science ®Google Scholar
• Omene, C. O.; Wu, J.; Frenkel, K. Caffeic Acid Phenethyl Ester (CAPE) derived from propolis, a honeybee product, inhibits growth of breast cancer stem cells. Invest. New Drugs. 2012, 30(4), 1279–1288. DOI: 10.1007/s10637-011-9667-8.
   PubMed Web of Science ®Google Scholar
• Beauregard, A. P.; Harquail, J.; Lassalle-Claux, G.; Belbraouet, M.; Jean-Francois, J.; Touaibia, M.; Robichaud, G. A. CAPE Analogs Induce Growth Arrest and Apoptosis in Breast Cancer Cells. Molecules. 2015, 20(7), 12576–12589. DOI: 10.3390/molecules200712576.
   PubMed Web of Science ®Google Scholar
• Wu, J.; Omene, C.; Karkoszka, J.; Bosland, M.; Eckard, J.; Klein, C. B.; Frenkel, K. Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancer. Cancer Lett. 2011, 308(1), 43–53. DOI: 10.1016/j.canlet.2011.04.012.
   PubMed Web of Science ®Google Scholar
• Watabe, M.; Hishikawa, K.; Takayanagi, A.; Shimizu, N.; Nakaki, T. Caffeic acid phenethyl ester induces apoptosis by inhibition of NFkappaB and activation of Fas in human breast cancer MCF-7 cells. J. Biol. Chem. 2004, 279(7), 6017–6026. DOI: 10.1074/jbc.M306040200.
   PubMed Web of Science ®Google Scholar
• Yi, X.; Zuo, J.; Tan, C.; Xian, S.; Luo, C.; Chen, S.; Yu, L.; Luo, Y. Kaempferol, a Flavonoid Compound from Gynura Medica Induced Apoptosis and Growth Inhibition in Mcf-7 Breast Cancer Cell. Afr. J. Tradit. Complement. Altern. Med. 2016, 13(4), 210–215. DOI: 10.21010/ajtcam.v13i4.27.
   PubMedGoogle Scholar
• Liao, W.; Chen, L.; Ma, X.; Jiao, R.; Li, X.; Wang, Y. Protective effects of kaempferol against reactive oxygen species-induced hemolysis and its antiproliferative activity on human cancer cells. Eur. J. Med. Chem. 2016, 114, 24–32. DOI: 10.1016/j.ejmech.2016.02.045.
   PubMed Web of Science ®Google Scholar
• Ahmed, H.; Moawad, A.; Owis, A.; AbouZid, S.; Ahmed, O. Flavonoids of Calligonum polygonoides and their cytotoxicity. Pharm. Biol. 2016, 54(10), 2119–2126. DOI: 10.3109/13880209.2016.1146778.
   PubMed Web of Science ®Google Scholar
• Zhu, L.; Xue, L. Kaempferol Suppresses Proliferation and Induces Cell Cycle Arrest, Apoptosis, and DNA Damage in Breast Cancer Cells. Oncol Res. 2019, 27(6), 629–634. DOI: 10.3727/096504018X15228018559434.
   PubMed Web of Science ®Google Scholar
• Ayob, Z.; Mohd Bohari, S. P.; Abd Samad, A.; Jamil, S. Cytotoxic Activities against Breast Cancer Cells of Local Justicia gendarussa Crude Extracts. Evid. Based Complement. Alternat. Med. 2014, 2014, 732980. DOI: 10.1155/2014/732980.
   PubMed Web of Science ®Google Scholar
• Choi, E. J.; Ahn, W. S. Kaempferol induced the apoptosis via cell cycle arrest in human breast cancer MDA-MB-453 cells. Nutr. Res. Pract. 2008, 2(4), 322–325. DOI: 10.4162/nrp.2008.2.4.322.
   PubMedGoogle Scholar
• Hu, G.; Liu, H.; Wang, M.; Peng, W.; Motif Containing, I. Q. GTPase-Activating Protein 3 (IQGAP3) Inhibits Kaempferol-Induced Apoptosis in Breast Cancer Cells by Extracellular Signal-Regulated Kinases 1/2 (ERK1/2) Signaling Activation. Med. Sci. Monit. 2019, 25, 7666–7674. DOI: 10.12659/MSM.915642.
   PubMed Web of Science ®Google Scholar
• Brusselmans, K.; Vrolix, R.; Verhoeven, G.; Swinnen, J. V. Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity. J. Biol. Chem. 2005, 280(7), 5636–5645. DOI: 10.1074/jbc.M408177200.
   PubMed Web of Science ®Google Scholar
• Li, S.; Yan, T.; Deng, R.; Jiang, X.; Xiong, H.; Wang, Y.; Yu, Q.; Wang, X.; Chen, C.; Zhu, Y. Low dose of kaempferol suppresses the migration and invasion of triple-negative breast cancer cells by downregulating the activities of RhoA and Rac1. Onco. Targets Ther. 2017, 10, 4809–4819. DOI: 10.2147/OTT.S140886.
   PubMed Web of Science ®Google Scholar
• Li, C.; Zhao, Y.; Yang, D.; Yu, Y.; Guo, H.; Zhao, Z.; Zhang, B.; Yin, X. Inhibitory effects of kaempferol on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9. Biochem. Cell Biol. 2015, 93(1), 16–27. DOI: 10.1139/bcb-2014-0067.
   PubMed Web of Science ®Google Scholar
• Phromnoi, K.; Yodkeeree, S.; Anuchapreeda, S.; Limtrakul, P. Inhibition of MMP-3 activity and invasion of the MDA-MB-231 human invasive breast carcinoma cell line by bioflavonoids. Acta Pharmacol. Sin. 2009, 30(8), 1169–1176. DOI: 10.1038/aps.2009.107.
   PubMed Web of Science ®Google Scholar
• Hashemzaei, M.; Delarami Far, A.; Yari, A.; Heravi, R. E.; Tabrizian, K.; Taghdisi, S. M.; Sadegh, S. E.; Tsarouhas, K.; Kouretas, D.; Tzanakakis, G., et al. Anticancer and apoptosisinducing effects of quercetin in vitro and in vivo. Oncol. Rep. 2017, 38(2), 819–828.
   PubMed Web of Science ®Google Scholar
• Ediriweera, M. K.; Tennekoon, K. H.; Samarakoon, S. R.; Thabrew, I.; de Silva, E. D. Protective Effects of Six Selected Dietary Compounds against Leptin-Induced Proliferation of Oestrogen Receptor Positive (MCF-7) Breast Cancer Cells. Med. (Basel). 2017, 4(3).
   PubMedGoogle Scholar
• Ranganathan, S.; Halagowder, D.; Sivasithambaram, N. D.; Singh, P. K. Quercetin Suppresses Twist to Induce Apoptosis in MCF-7 Breast Cancer Cells. PloS one. 2015, 10(10), e0141370. DOI: 10.1371/journal.pone.0141370.
   PubMed Web of Science ®Google Scholar
• Xintaropoulou, C.; Ward, C.; Wise, A.; Marston, H.; Turnbull, A.; Langdon, S. P. A comparative analysis of inhibitors of the glycolysis pathway in breast and ovarian cancer cell line models. Oncotarget. 2015, 6(28), 25677–25695. DOI: 10.18632/oncotarget.4499.
   PubMedGoogle Scholar
• Zhang, H.; Zhang, M.; Yu, L.; Zhao, Y.; He, N.; Yang, X. Antitumor activities of quercetin and quercetin-5ʹ,8-disulfonate in human colon and breast cancer cell lines. Food Chem. Toxicol. 2012, 50(5), 1589–1599. DOI: 10.1016/j.fct.2012.01.025.
   PubMed Web of Science ®Google Scholar
• Duo, J.; Ying, G. G.; Wang, G. W.; Zhang, L. Quercetin inhibits human breast cancer cell proliferation and induces apoptosis via Bcl-2 and Bax regulation. Mol. Med. Rep. 2012, 5(6), 1453–1456. DOI: 10.3892/mmr.2012.845.
   PubMed Web of Science ®Google Scholar
• Rahimifard, M.; Sadeghi, F.; Asadi-Samani, M.; Nejati-Koshki, K. Effect of quercetin on secretion and gene expression of leptin in breast cancer. J Tradit Chin Med. 2017, 37(3), 321–325. DOI: 10.1016/S0254-6272(17)30067-5.
   PubMed Web of Science ®Google Scholar
• Balabhadrapathruni, S.; Thomas, T. J.; Yurkow, E. J.; Amenta, P. S.; Thomas, T. Effects of genistein and structurally related phytoestrogens on cell cycle kinetics and apoptosis in MDA-MB-468 human breast cancer cells. Oncol. Rep. 2000, 7(1), 3–12.
   PubMed Web of Science ®Google Scholar
• Srivastava, S.; Somasagara, R. R.; Hegde, M.; Nishana, M.; Tadi, S. K.; Srivastava, M.; Choudhary, B.; Raghavan, S. C. Quercetin, a Natural Flavonoid Interacts with DNA, Arrests Cell Cycle and Causes Tumor Regression by Activating Mitochondrial Pathway of Apoptosis. Sci. Rep. 2016, 6(1), 24049. DOI: 10.1038/srep24049.
   PubMed Web of Science ®Google Scholar
• Wu, Q.; Needs, P. W.; Lu, Y.; Kroon, P. A.; Ren, D.; Yang, X. Different antitumor effects of quercetin, quercetin-3ʹ-sulfate and quercetin-3-glucuronide in human breast cancer MCF-7 cells. Food Funct. 2018, 9(3), 1736–1746. DOI: 10.1039/C7FO01964E.
   PubMed Web of Science ®Google Scholar
• Tao, S. F.; He, H. F.; Chen, Q. Quercetin inhibits proliferation and invasion acts by up-regulating miR-146a in human breast cancer cells. Mol. Cell. Biochem. 2015, 402(1–2), 93–100. DOI: 10.1007/s11010-014-2317-7.
   PubMed Web of Science ®Google Scholar
• Dhumale, S. S.; Waghela, B. N.; Pathak, C. Quercetin protects necrotic insult and promotes apoptosis by attenuating the expression of RAGE and its ligand HMGB1 in human breast adenocarcinoma cells. IUBMB life. 2015, 67(5), 361–373. DOI: 10.1002/iub.1379.
   PubMed Web of Science ®Google Scholar
• Deng, X. H.; Song, H. Y.; Zhou, Y. F.; Yuan, G. Y.; Zheng, F. J. Effects of quercetin on the proliferation of breast cancer cells and expression of survivin in vitro. Exp. Ther. Med. 2013, 6(5), 1155–1158. DOI: 10.3892/etm.2013.1285.
   PubMed Web of Science ®Google Scholar
• Chou, C. C.; Yang, J. S.; Lu, H. F.; Ip, S. W.; Lo, C.; Wu, C. C.; Lin, J. P.; Tang, N. Y.; Chung, J. G.; Chou, M. J., et al. Quercetin-mediated cell cycle arrest and apoptosis involving activation of a caspase cascade through the mitochondrial pathway in human breast cancer MCF-7 cells. Arch. Pharm. Res. 2010, 33(8), 1181–1191.
   PubMed Web of Science ®Google Scholar
• Choi, J. A.; Kim, J. Y.; Lee, J. Y.; Kang, C. M.; Kwon, H. J.; Yoo, Y. D.; Kim, T. W.; Lee, Y. S.; Lee, S. J. Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin. Int. j. oncol. 2001, 19(4), 837–844. DOI: 10.3892/ijo.19.4.837.
   PubMed Web of Science ®Google Scholar
• Nguyen, L. T.; Lee, Y. H.; Sharma, A. R.; Park, J. B.; Jagga, S.; Sharma, G.; Lee, S. S.; Nam, J. S. Quercetin induces apoptosis and cell cycle arrest in triple-negative breast cancer cells through modulation of Foxo3a activity. Korean J. Physiol. Pharmacol. 2017, 21(2), 205–213. DOI: 10.4196/kjpp.2017.21.2.205.
   PubMed Web of Science ®Google Scholar
• Chien, S. Y.; Wu, Y. C.; Chung, J. G.; Yang, J. S.; Lu, H. F.; Tsou, M. F.; Wood, W. G.; Kuo, S. J.; Chen, D. R. Quercetin-induced apoptosis acts through mitochondrial- and caspase-3-dependent pathways in human breast cancer MDA-MB-231 cells. Hum. Exp. Toxicol. 2009, 28(8), 493–503. DOI: 10.1177/0960327109107002.
   PubMed Web of Science ®Google Scholar
• Choi, E. J.; Bae, S. M.; Ahn, W. S. Antiproliferative effects of quercetin through cell cycle arrest and apoptosis in human breast cancer MDA-MB-453 cells. Arch. Pharm. Res. 2008, 31(10), 1281–1285. DOI: 10.1007/s12272-001-2107-0.
   PubMed Web of Science ®Google Scholar
• Seo, H. S.; Ku, J. M.; Choi, H. S.; Choi, Y. K.; Woo, J. K.; Kim, M.; Kim, I.; Na, C. H.; Hur, H.; Jang, B. H., et al. Quercetin induces caspase-dependent extrinsic apoptosis through inhibition of signal transducer and activator of transcription 3 signaling in HER2-overexpressing BT-474 breast cancer cells. Oncol. Rep. 2016, 36(1), 31–42.
   PubMed Web of Science ®Google Scholar
• Noolu, B.; Gogulothu, R.; Bhat, M.; Qadri, S. S.; Reddy, V. S.; Reddy, G. B.; Ismail, A. In Vivo Inhibition of Proteasome Activity and Tumour Growth by Murraya koenigii Leaf Extract in Breast Cancer Xenografts and by Its Active Flavonoids in Breast Cancer Cells. Anti Cancer Agents Med. Chem. 2016, 16(12), 1605–1614. DOI: 10.2174/1871520616666160520112210.
   PubMed Web of Science ®Google Scholar
• Rivera Rivera, A.; Castillo-Pichardo, L.; Gerena, Y.; Dharmawardhane, S.; Tan, M. Anti-Breast Cancer Potential of Quercetin via the Akt/AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Cascade. PloS one. 2016, 11(6), e0157251. DOI: 10.1371/journal.pone.0157251.
   PubMed Web of Science ®Google Scholar
• Srinivasan, A.; Thangavel, C.; Liu, Y.; Shoyele, S.; Den, R. B.; Selvakumar, P.; Lakshmikuttyamma, A. Quercetin regulates beta-catenin signaling and reduces the migration of triple negative breast cancer. Mol. Carcinog. 2016, 55(5), 743–756. DOI: 10.1002/mc.22318.
   PubMed Web of Science ®Google Scholar
• Song, W.; Yan, C. Y.; Zhou, Q. Q.; Zhen, L. L. Galangin potentiates human breast cancer to apoptosis induced by TRAIL through activating AMPK. Biomed. Pharmacother. 2017, 89, 845–856. DOI: 10.1016/j.biopha.2017.01.062.
   PubMed Web of Science ®Google Scholar
• Murray, T. J.; Yang, X.; Sherr, D. H. Growth of a human mammary tumor cell line is blocked by galangin, a naturally occurring bioflavonoid, and is accompanied by down-regulation of cyclins D3, E, and A. Breast Cancer Res. 2006, 8(2), R17. DOI: 10.1186/bcr1391.
   PubMed Web of Science ®Google Scholar
• Samarghandian, S.; Azimi-Nezhad, M.; Borji, A.; Hasanzadeh, M.; Jabbari, F.; Farkhondeh, T.; Samini, M. Inhibitory and Cytotoxic Activities of Chrysin on Human Breast Adenocarcinoma Cells by Induction of Apoptosis. Pharmacogn. Mag. 2016, 12(Suppl 4), S436–S440. DOI: 10.4103/0973-1296.191453.
   PubMedGoogle Scholar
• Rasouli, S.; Zarghami, N. Synergistic Growth Inhibitory Effects of Chrysin and Metformin Combination on Breast Cancer Cells through hTERT and Cyclin D1 Suppression. Asian Pac. J. Cancer Prev. 2018, 19(4), 977–982. DOI: 10.22034/APJCP.2018.19.4.977.
   PubMedGoogle Scholar
• Javan Maasomi, Z.; Pilehvar Soltanahmadi, Y.; Dadashpour, M.; Alipour, S.; Abolhasani, S.; Zarghami, N. Synergistic Anticancer Effects of Silibinin and Chrysin in T47D Breast Cancer Cells. Asian Pac. J. Cancer Prev. 2017, 18(5), 1283–1287. DOI: 10.22034/APJCP.2017.18.5.1283.
   PubMedGoogle Scholar
• Mahin, M.; Ali, A.; Elahe, K.; Naser, A.; Elahe, K.; Shaahin, S.; Nader, S.; Naser, A. Synthesis of a copolymer carrier for anticancer drug luteolin for targeting human breast cancer cells. J Tradit Chin Med. 2019, 39(4), 474–481.
   PubMed Web of Science ®Google Scholar
• Mira, A.; Shimizu, K. In vitro Cytotoxic Activities and Molecular Mechanisms of Angelica shikokiana Extract and its Isolated Compounds. Pharmacogn. Mag. 2015, 11(Suppl 4), S564–9. DOI: 10.4103/0973-1296.172962.
   PubMedGoogle Scholar
• Lin, C. H.; Chang, C. Y.; Lee, K. R.; Lin, H. J.; Chen, T. H.; Wan, L. Flavones inhibit breast cancer proliferation through the Akt/FOXO3a signaling pathway. BMC cancer. 2015, 15(1), 958. DOI: 10.1186/s12885-015-1965-7.
   PubMedGoogle Scholar
• Huang, L.; Jin, K.; Lan, H. Luteolin inhibits cell cycle progression and induces apoptosis of breast cancer cells through downregulation of human telomerase reverse transcriptase. Oncol. Letters. 2019, 17(4), 3842–3850. DOI: 10.3892/ol.2019.10052.
   PubMed Web of Science ®Google Scholar
• Cao, D.; Zhu, G. Y.; Lu, Y.; Yang, A.; Chen, D.; Huang, H. J.; Peng, S. X.; Chen, L. W.; Li, Y. W. Luteolin suppresses epithelial-mesenchymal transition and migration of triple-negative breast cancer cells by inhibiting YAP/TAZ activity. Biomed. Pharmacother. 2020, 129, 110462. DOI: 10.1016/j.biopha.2020.110462.
   PubMed Web of Science ®Google Scholar
• Gao, G.; Ge, R.; Li, Y.; Liu, S. Luteolin exhibits anti-breast cancer property through up-regulating miR-203. Artif. Cells Nanomed. Biotechnol. 2019, 47(1), 3265–3271. DOI: 10.1080/21691401.2019.1646749.
   PubMed Web of Science ®Google Scholar
• Park, S. H.; Ham, S.; Kwon, T. H.; Kim, M. S.; Lee, D. H.; Kang, J. W.; Oh, S. R.; Yoon, D. Y. Luteolin induces cell cycle arrest and apoptosis through extrinsic and intrinsic signaling pathways in MCF-7 breast cancer cells. J Environ Pathol Toxicol Oncol. 2014, 33(3), 219–231. DOI: 10.1615/JEnvironPatholToxicolOncol.2014010923.
   PubMed Web of Science ®Google Scholar
• Magura, J.; Moodley, R.; Mackraj, I. The effect of hesperidin and luteolin isolated from Eriocephalus africanus on apoptosis, cell cycle and miRNA expression in MCF-7. J. biomol. struct. dyn. 2020, 1–10. doi:10.1080/07391102.2020.1833757.
   Web of Science ®Google Scholar
• Lee, E. J.; Oh, S. Y.; Sung, M. K. Luteolin exerts anti-tumor activity through the suppression of epidermal growth factor receptor-mediated pathway in MDA-MB-231 ER-negative breast cancer cells. Food Chem. Toxicol. 2012, 50(11), 4136–4143. DOI: 10.1016/j.fct.2012.08.025.
   PubMed Web of Science ®Google Scholar
• Dong, X.; Zheng, T.; Zhang, Z.; Bai, X.; Li, H.; Zhang, J. [Luteolin reverses OPCML methylation to inhibit proliferation of breast cancer MDA-MB-231 cells]. Nan fang yi ke da xue xue bao = J. South. Med. Univ. 2020, 40(4), 550–555. DOI: 10.12122/j.issn.1673-4254.2020.04.16.
   PubMedGoogle Scholar
• Monti, E.; Marras, E.; Prini, P.; Gariboldi, M. B. Luteolin impairs hypoxia adaptation and progression in human breast and colon cancer cells. Eur. J. Pharmacol. 2020, 881, 173210. DOI: 10.1016/j.ejphar.2020.173210.
   PubMed Web of Science ®Google Scholar
• Lee, J.; Park, S. H.; Lee, J.; Chun, H.; Choi, M. K.; Yoon, J. H.; Pham, T. H.; Kim, K. H.; Kwon, T.; Ryu, H. W., et al. Differential effects of luteolin and its glycosides on invasion and apoptosis in MDA-MB-231 triple-negative breast cancer cells. EXCLI J. 2019, 18, 750–763. DOI: 10.17179/excli2019-1459.
   PubMed Web of Science ®Google Scholar
• Feng, J.; Zheng, T.; Hou, Z.; Lv, C.; Xue, A.; Han, T.; Han, B.; Sun, X.; Wei, Y. Luteolin, an aryl hydrocarbon receptor ligand, suppresses tumor metastasis in vitro and in vivo. Oncol. Rep. 2020, 44(5), 2231–2240. DOI: 10.3892/or.2020.7781.
   PubMed Web of Science ®Google Scholar
• Sun, D. W.; Zhang, H. D.; Mao, L.; Mao, C. F.; Chen, W.; Cui, M.; Ma, R.; Cao, H. X.; Jing, C. W.; Wang, Z., et al. Luteolin Inhibits Breast Cancer Development and Progression In Vitro and In Vivo by Suppressing Notch Signaling and Regulating MiRNAs. Cellular Physiol. Biochem. 2015, 37(5), 1693–1711.
   PubMedGoogle Scholar
• Jiang, Y.; Xie, K. P.; Huo, H. N.; Wang, L. M.; Zou, W.; Xie, M. J. [Inhibitory effect of luteolin on the angiogenesis of chick chorioallantoic membrane and invasion of breast cancer cells via downregulation of AEG-1 and MMP-2]. Sheng Li Xue Bao. 2013, 65(5), 513–518.
   PubMedGoogle Scholar
• Lin, D.; Kuang, G.; Wan, J.; Zhang, X.; Li, H.; Gong, X.; Li, H. Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of beta-catenin expression. Oncol. Rep. 2017, 37(2), 895–902. DOI: 10.3892/or.2016.5311.
   PubMed Web of Science ®Google Scholar
• Sordon, S.; Poplonski, J.; Milczarek, M.; Stachowicz, M.; Tronina, T.; Kucharska, A. Z.; Wietrzyk, J.; Huszcza, E. Structure-Antioxidant-Antiproliferative Activity Relationships of Natural C7 and C7-C8 Hydroxylated Flavones and Flavanones. Antioxidants (Basel). 2019, 8(7). DOI: 10.3390/antiox8070210.
   PubMedGoogle Scholar
• Grigalius, I.; Petrikaite, V. Relationship between Antioxidant and Anticancer Activity of Trihydroxyflavones. Molecules. 2017, 22(12), 2169. DOI: 10.3390/molecules22122169.
   PubMed Web of Science ®Google Scholar
• Bai, H.; Jin, H.; Yang, F.; Zhu, H.; Cai, J. Apigenin induced MCF-7 cell apoptosis-associated reactive oxygen species. Scanning. 2014, 36(6), 622–631. DOI: 10.1002/sca.21170.
   PubMed Web of Science ®Google Scholar
• Vrhovac Madunic, I.; Madunic, J.; Antunovic, M.; Paradzik, M.; Garaj-Vrhovac, V.; Breljak, D.; Marijanovic, I.; Gajski, G. Apigenin, a dietary flavonoid, induces apoptosis, DNA damage, and oxidative stress in human breast cancer MCF-7 and MDA MB-231 cells. Naunyn-Schmiedeberg’s Arch. Pharmacol. 2018, 391(5), 537–550. DOI: 10.1007/s00210-018-1486-4.
   Google Scholar
• Scherbakov, A. M.; Andreeva, O. E. Apigenin Inhibits Growth of Breast Cancer Cells: The Role of ERalpha and HER2/neu. Acta Naturae. 2015, 7(3), 133–139. DOI: 10.32607/20758251-2015-7-3-133-139.
   PubMed Web of Science ®Google Scholar
• Shendge, A. K.; Chaudhuri, D.; Basu, T.; Mandal, N. A natural flavonoid, apigenin isolated from Clerodendrum viscosum leaves, induces G2/M phase cell cycle arrest and apoptosis in MCF-7 cells through the regulation of p53 and caspase-cascade pathway. Clin. Trans. Oncol. 2021, 23(4), 718–730. DOI: 10.1007/s12094-020-02461-0.
   PubMed Web of Science ®Google Scholar
• Cao, X.; Liu, B.; Cao, W.; Zhang, W.; Zhang, F.; Zhao, H.; Meng, R.; Zhang, L.; Niu, R.; Hao, X., et al. Autophagy inhibition enhances apigenin-induced apoptosis in human breast cancer cells. Chin. J. Cancer Res. 2013, 25(2), 212–222.
   PubMed Web of Science ®Google Scholar
• Chen, W. Y.; Hsieh, Y. A.; Tsai, C. I.; Kang, Y. F.; Chang, F. R.; Wu, Y. C.; Wu, C. C. Protoapigenone, a natural derivative of apigenin, induces mitogen-activated protein kinase-dependent apoptosis in human breast cancer cells associated with induction of oxidative stress and inhibition of glutathione S-transferase pi. Invest. New Drugs. 2011, 29(6), 1347–1359. DOI: 10.1007/s10637-010-9497-0.
   PubMed Web of Science ®Google Scholar
• Sinha, S.; Patel, S.; Athar, M.; Vora, J.; Chhabria, M. T.; Jha, P. C.; Shrivastava, N. Structure-based identification of novel sirtuin inhibitors against triple negative breast cancer: An in silico and in vitro study. Int. J. Biol. Macromol. 2019, 140, 454–468. DOI: 10.1016/j.ijbiomac.2019.08.061.
   PubMed Web of Science ®Google Scholar
• Seo, H. S.; Ku, J. M.; Choi, H. S.; Woo, J. K.; Jang, B. H.; Shin, Y. C.; Ko, S. G. Induction of caspase-dependent apoptosis by apigenin by inhibiting STAT3 signaling in HER2-overexpressing MDA-MB-453 breast cancer cells. Anticancer Res. 2014, 34(6), 2869–2882.
   PubMed Web of Science ®Google Scholar
• Choi, E. J.; Kim, G. H. Apigenin Induces Apoptosis through a Mitochondria/Caspase-Pathway in Human Breast Cancer MDA-MB-453 Cells. J. Clin. Biochem. Nutr. 2009, 44(3), 260–265. DOI: 10.3164/jcbn.08-230.
   PubMed Web of Science ®Google Scholar
• Seo, H. S.; Ku, J. M.; Choi, H. S.; Woo, J. K.; Jang, B. H.; Go, H.; Shin, Y. C.; Ko, S. G. Apigenin induces caspase-dependent apoptosis by inhibiting signal transducer and activator of transcription 3 signaling in HER2-overexpressing SKBR3 breast cancer cells. Mol. Med. Rep. 2015, 12(2), 2977–2984. DOI: 10.3892/mmr.2015.3698.
   PubMed Web of Science ®Google Scholar
• Seo, H. S.; Jo, J. K.; Ku, J. M.; Choi, H. S.; Choi, Y. K.; Woo, J. K.; Kim, H. I.; Kang, S. Y.; Lee, K. M.; Nam, K. W., et al. Induction of caspase-dependent extrinsic apoptosis by apigenin through inhibition of signal transducer and activator of transcription 3 (STAT3) signalling in HER2-overexpressing BT-474 breast cancer cells. Biosci. Rep. 2015, 35(6). doi:10.1042/BSR20150165.
   PubMedGoogle Scholar
• Ittiudomrak, T.; Puthong, S.; Palaga, T.; Roytrakul, S.; Chanchao, C. α-Mangostin and apigenin induced the necrotic death of BT474 breast cancer cells with autophagy and inflammation. Asian Pac. J. Trop. Biomed. 2018, 8(11), 519. DOI: 10.4103/2221-1691.245956.
   Web of Science ®Google Scholar
• Mak, P.; Leung, Y. K.; Tang, W. Y.; Harwood, C.; Ho, S. M. Apigenin suppresses cancer cell growth through ERbeta. Neoplasia. 2006, 8(11), 896–904. DOI: 10.1593/neo.06538.
   PubMed Web of Science ®Google Scholar
• Chen, D.; Landis-Piwowar, K. R.; Chen, M. S.; Dou, Q. P. Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenografts. Breast Cancer Res. 2007, 9(6), R80. DOI: 10.1186/bcr1797.
   PubMed Web of Science ®Google Scholar
• Way, T. D.; Kao, M. C.; Lin, J. K. Degradation of HER2/neu by apigenin induces apoptosis through cytochrome c release and caspase-3 activation in HER2/neu-overexpressing breast cancer cells. FEBS Lett. 2005, 579(1), 145–152. DOI: 10.1016/j.febslet.2004.11.061.
   PubMed Web of Science ®Google Scholar
• Way, T. D.; Kao, M. C.; Lin, J. K. Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway. J. Biol. Chem. 2004, 279(6), 4479–4489. DOI: 10.1074/jbc.M305529200.
   PubMed Web of Science ®Google Scholar
• Harrison, M. E.; Power Coombs, M. R.; Delaney, L. M.; Hoskin, D. W. Exposure of breast cancer cells to a subcytotoxic dose of apigenin causes growth inhibition, oxidative stress, and hypophosphorylation of Akt. Exp. Mol. Pathol. 2014, 97(2), 211–217. DOI: 10.1016/j.yexmp.2014.07.006.
   PubMed Web of Science ®Google Scholar
• Yin, F.; Giuliano, A. E.; Law, R. E.; Van Herle, A. J. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells. Anticancer Res. 2001, 21(1A), 413–420.
   PubMed Web of Science ®Google Scholar
• Lee, H. H.; Jung, J.; Moon, A.; Kang, H.; Cho, H. Antitumor and Anti-Invasive Effect of Apigenin on Human Breast Carcinoma through Suppression of IL-6 Expression. Int. J. Mol. Sci. 2019, 20(13).
   Web of Science ®Google Scholar
• Li, Y. W.; Xu, J.; Zhu, G. Y.; Huang, Z. J.; Lu, Y.; Li, X. Q.; Wang, N.; Zhang, F. X. Apigenin suppresses the stem cell-like properties of triple-negative breast cancer cells by inhibiting YAP/TAZ activity. Cell Death Discov. 2018, 4(1), 105. DOI: 10.1038/s41420-018-0124-8.
   PubMedGoogle Scholar
• Saleh, A.; ElFayoumi, H. M.; Youns, M.; Barakat, W. Rutin and orlistat produce antitumor effects via antioxidant and apoptotic actions. Naunyn-Schmiedeberg’s Arch. Pharmacol. 2019, 392(2), 165–175. DOI: 10.1007/s00210-018-1579-0.
   Google Scholar
• Basu, P.; Meza, E.; Bergel, M.; Maier, C. Estrogenic, Antiestrogenic and Antiproliferative Activities of Euphorbia bicolor (Euphorbiaceae) Latex Extracts and Its Phytochemicals. Nutrients. 2019, 12(1), 59. DOI: 10.3390/nu12010059.
   PubMed Web of Science ®Google Scholar
• Elsayed, H. E.; Ebrahim, H. Y.; Mohyeldin, M. M.; Siddique, A. B.; Kamal, A. M.; Haggag, E. G.; El Sayed, K. A. Rutin as A Novel c-Met Inhibitory Lead for The Control of Triple Negative Breast Malignancies. Nutr. Cancer. 2017, 69(8), 1256–1271. DOI: 10.1080/01635581.2017.1367936.
   PubMed Web of Science ®Google Scholar
• Deepika, M. S.; Thangam, R.; Sheena, T. S.; Vimala, R. T. V.; Sivasubramanian, S.; Jeganathan, K.; Thirumurugan, R. Dual drug loaded PLGA nanospheres for synergistic efficacy in breast cancer therapy. Mater. sci. eng. C Mater. biol. appl. 2019, 103, 109716. DOI: 10.1016/j.msec.2019.05.001.
   PubMed Web of Science ®Google Scholar
• Iriti, M.; Kubina, R.; Cochis, A.; Sorrentino, R.; Varoni, E. M.; Kabala-Dzik, A.; Azzimonti, B.; Dziedzic, A.; Rimondini, L.; Wojtyczka, R. D. Rutin, a Quercetin Glycoside, Restores Chemosensitivity in Human Breast Cancer Cells. Phytother Res. 2017, 31(10), 1529–1538. DOI: 10.1002/ptr.5878.
   PubMed Web of Science ®Google Scholar
• Diaz-Carballo, D.; Freista Hler, M.; Malak, S.; Bardenheuer, W.; Reusch, H. P. Mucronulatol from Caribbean propolis exerts cytotoxic effects on human tumor cell lines. Int J Clin Pharmacol Ther. 2008, 46(5), 226–235. DOI: 10.5414/CPP46226.
   PubMed Web of Science ®Google Scholar
• Attari, F.; Keighobadi, F.; Abdollahi, M.; Arefian, E.; Lotfizadeh, R.; Sepehri, H.; Moridi Farimani, M. Inhibitory effect of flavonoid xanthomicrol on triple-negative breast tumor via regulation of cancer-associated microRNAs. Phytother Res. 2020, 35(4), 1967–1982. DOI: 10.1002/ptr.6940.
   PubMed Web of Science ®Google Scholar
• Wadhwa, R.; Nigam, N.; Bhargava, P.; Dhanjal, J. K.; Goyal, S.; Grover, A.; Sundar, D.; Ishida, Y.; Terao, K.; Kaul, S. C. Molecular Characterization and Enhancement of Anticancer Activity of Caffeic Acid Phenethyl Ester by gamma Cyclodextrin. J. Cancer. 2016, 7(13), 1755–1771. DOI: 10.7150/jca.15170.
   PubMed Web of Science ®Google Scholar
• Omene, C.; Kalac, M.; Wu, J.; Marchi, E.; Frenkel, K.; O’Connor, O. A. Propolis and its Active Component, Caffeic Acid Phenethyl Ester (CAPE), Modulate Breast Cancer Therapeutic Targets via an Epigenetically Mediated Mechanism of Action. J. Cancer Sci. Ther. 2013, 5(10), 334–342.
   PubMedGoogle Scholar
• Fraser, S. P.; Hemsley, F.; Djamgoz, M. B. A. Caffeic acid phenethyl ester: Inhibition of metastatic cell behaviours via voltage-gated sodium channel in human breast cancer in vitro. Int. J. Biochem. Cell Biol. 2016, 71, 111–118. DOI: 10.1016/j.biocel.2015.12.012.
   PubMed Web of Science ®Google Scholar
• Balc-Okcanoğlu, T.; Yilma-Susluer, S.; Kayabasi, C.; Ozme-Yelken, B.; Biray-Avci, C.; Gunduz, C. The effect of caffeic acid phenethyl ester on cell cycle control gene expressions in breast cancer cells. Mol. Biol. Res. Commun. 2021, 10(1), 39–43. DOI: 10.22099/mbrc.2020.38811.1563.
   PubMed Web of Science ®Google Scholar
• Jung, B. I.; Kim, M. S.; Kim, H. A.; Kim, D.; Yang, J.; Her, S.; Song, Y. S. Caffeic acid phenethyl ester, a component of beehive propolis, is a novel selective estrogen receptor modulator. Phytother Res. 2010, 24(2), 295–300. DOI: 10.1002/ptr.2966.
   PubMed Web of Science ®Google Scholar
• Kim, B. W.; Lee, E. R.; Min, H. M.; Jeong, H. S.; Ahn, J. Y.; Kim, J. H.; Choi, H. Y.; Choi, H.; Kim, E. Y.; Park, S. P., et al. Sustained ERK activation is involved in the kaempferol-induced apoptosis of breast cancer cells and is more evident under 3-D culture condition. Cancer Biol. Ther. 2008, 7(7), 1080–1089.
   PubMed Web of Science ®Google Scholar
• Hung, H. Inhibition of estrogen receptor alpha expression and function in MCF-7 cells by kaempferol. J. Cell. Physiol. 2004, 198(2), 197–208. DOI: 10.1002/jcp.10398.
   PubMed Web of Science ®Google Scholar
• Azevedo, C.; Correia-Branco, A.; Araujo, J. R.; Guimaraes, J. T.; Keating, E.; Martel, F. The chemopreventive effect of the dietary compound kaempferol on the MCF-7 human breast cancer cell line is dependent on inhibition of glucose cellular uptake. Nutr. Cancer. 2015, 67(3), 504–513. DOI: 10.1080/01635581.2015.1002625.
   PubMed Web of Science ®Google Scholar
• Khorsandi, L.; Orazizadeh, M.; Niazvand, F.; Abbaspour, M. R.; Mansouri, E.; Khodadadi, A. Quercetin induces apoptosis and necroptosis in MCF-7 breast cancer cells. Bratisl Lek Listy. 2017, 118(2), 123–128. DOI: 10.4149/BLL_2017_025.
   PubMed Web of Science ®Google Scholar
• Yang, W.; Cui, M.; Lee, J.; Gong, W.; Wang, S.; Fu, J.; Wu, G.; Yan, K. Heat shock protein inhibitor, quercetin, as a novel adjuvant agent to improve radiofrequency ablation-induced tumor destruction and its molecular mechanism. Chin. J. Cancer Res. 2016, 28(1), 19–28. DOI: 10.3978/j.issn.1000-9604.2016.02.06.
   PubMed Web of Science ®Google Scholar
• Chen, F. P.; Chien, M. H. Phytoestrogens induce apoptosis through a mitochondria/caspase pathway in human breast cancer cells. Climacteric. 2014, 17(4), 385–392. DOI: 10.3109/13697137.2013.869671.
   PubMed Web of Science ®Google Scholar
• Lee, Y. K.; Park, S. Y.; Kim, Y. M.; Lee, W. S.; Park, O. J. AMP kinase/cyclooxygenase-2 pathway regulates proliferation and apoptosis of cancer cells treated with quercetin. Exp. Mol. Med. 2009, 41(3), 201–207. DOI: 10.3858/emm.2009.41.3.023.
   PubMed Web of Science ®Google Scholar
• Seo, H. S.; Choi, H. S.; Choi, H. S.; Choi, Y. K.; Um, J. Y.; Choi, I.; Shin, Y. C.; Ko, S. G. Phytoestrogens induce apoptosis via extrinsic pathway, inhibiting nuclear factor-kappaB signaling in HER2-overexpressing breast cancer cells. Anticancer Res. 2011, 31(10), 3301–3313.
   PubMed Web of Science ®Google Scholar
• Chen, F. P.; Chien, M. H. Effects of phytoestrogens on the activity and growth of primary breast cancer cells ex vivo. J Obstet Gynaecol Res. 2019, 45(7), 1352–1362. DOI: 10.1111/jog.13982.
   PubMed Web of Science ®Google Scholar
• Kıyga, E.; Şengelen, A.; Adıgüzel, Z.; Önay Uçar, E. Investigation of the role of quercetin as a heat shock protein inhibitor on apoptosis in human breast cancer cells. Mol. Biol. Rep. 2020, 47(7), 4957–4967. DOI: 10.1007/s11033-020-05641-x.
   PubMed Web of Science ®Google Scholar
• Waite, K. A.; Sinden, M. R.; Eng, C. Phytoestrogen exposure elevates PTEN levels. Hum. Mol. Genet. 2005, 14(11), 1457–1463. DOI: 10.1093/hmg/ddi155.
   PubMed Web of Science ®Google Scholar
• Hwang, E. Y.; Huh, J. W.; Choi, M. M.; Choi, S. Y.; Hong, H. N.; Cho, S. W. Inhibitory effects of gallic acid and quercetin on UDP-glucose dehydrogenase activity. FEBS Lett. 2008, 582(27), 3793–3797. DOI: 10.1016/j.febslet.2008.10.010.
   PubMed Web of Science ®Google Scholar
• Li, L. J.; Li, G. W.; Xie, Y. [Regulatory effects of glabridin and quercetin on energy metabolism of breast cancer cells]. Zhongguo Zhong Yao Za Zhi. 2019, 44(17), 3786–3791. DOI: 10.19540/j.cnki.cjcmm.20190505.401.
   PubMedGoogle Scholar
• Sharma, R.; Gatchie, L.; Williams, I. S.; Jain, S. K.; Vishwakarma, R. A.; Chaudhuri, B.; Bharate, S. B. Glycyrrhiza glabra extract and quercetin reverses cisplatin resistance in triple-negative MDA-MB-468 breast cancer cells via inhibition of cytochrome P450 1B1 enzyme. Bioorg. Med. Chem. Lett. 2017, 27(24), 5400–5403. DOI: 10.1016/j.bmcl.2017.11.013.
   PubMed Web of Science ®Google Scholar
• Conklin, C. M.; Bechberger, J. F.; MacFabe, D.; Guthrie, N.; Kurowska, E. M.; Naus, C. C. Genistein and quercetin increase connexin43 and suppress growth of breast cancer cells. Carcinogenesis. 2007, 28(1), 93–100. DOI: 10.1093/carcin/bgl106.
   PubMed Web of Science ®Google Scholar
• Hanikoglu, A.; Kucuksayan, E.; Hanikoglu, F.; Ozben, T.; Menounou, G.; Sansone, A.; Chatgilialoglu, C.; Di Bella, G.; Ferreri, C. Effects of somatostatin, curcumin, and quercetin on the fatty acid profile of breast cancer cell membranes. Can. J. Physiol. Pharmacol. 2020, 98(3), 131–138. DOI: 10.1139/cjpp-2019-0352.
   PubMed Web of Science ®Google Scholar
• Wang, R.; Yang, L.; Li, S.; Ye, D.; Yang, L.; Liu, Q.; Zhao, Z.; Cai, Q.; Tan, J.; Li, X. Quercetin Inhibits Breast Cancer Stem Cells via Downregulation of Aldehyde Dehydrogenase 1A1 (ALDH1A1), Chemokine Receptor Type 4 (CXCR4), Mucin 1 (MUC1), and Epithelial Cell Adhesion Molecule (EpCAM). Med. Sci. Monit. 2018, 24, 412–420. DOI: 10.12659/MSM.908022.
   PubMed Web of Science ®Google Scholar
• Lee, Y. K.; Park, O. J. Regulation of mutual inhibitory activities between AMPK and Akt with quercetin in MCF-7 breast cancer cells. Oncol. Rep. 2010, 24(6), 1493–1497. DOI: 10.3892/or_00001010.
   PubMed Web of Science ®Google Scholar
• Li, Y.; Li, R.; Zeng, Z.; Li, S.; Luo, S.; Wu, J.; Zhou, C.; Xu, D. Prediction of the mechanisms of Xiaoai Jiedu Recipe in the treatment of breast cancer: A comprehensive approach study with experimental validation. J. Ethnopharmacol. 2020, 252, 112603. DOI: 10.1016/j.jep.2020.112603.
   PubMed Web of Science ®Google Scholar
• Castillo-Pichardo, L.; Dharmawardhane, S. F. Grape polyphenols inhibit Akt/mammalian target of rapamycin signaling and potentiate the effects of gefitinib in breast cancer. Nutr. Cancer. 2012, 64(7), 1058–1069. DOI: 10.1080/01635581.2012.716898.
   PubMed Web of Science ®Google Scholar
• van Zanden, J. J.; Geraets, L.; Wortelboer, H. M.; van Bladeren, P. J.; Rietjens, I. M.; Cnubben, N. H. Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells. Biochem Pharmacol. 2004, 67(8), 1607–1617. DOI: 10.1016/j.bcp.2003.12.032.
   PubMed Web of Science ®Google Scholar
• Ciolino, H. P.; Yeh, G. C. The flavonoid galangin is an inhibitor of CYP1A1 activity and an agonist/antagonist of the aryl hydrocarbon receptor. Br. j. cancer. 1999, 79(9–10), 1340–1346. DOI: 10.1038/sj.bjc.6690216.
   PubMed Web of Science ®Google Scholar
• Aryappalli, P.; Shabbiri, K.; Masad, R. J.; Al-Marri, R. H.; Haneefa, S. M.; Mohamed, Y. A.; Arafat, K.; Attoub, S.; Cabral-Marques, O.; Ramadi, K. B., et al. Inhibition of Tyrosine-Phosphorylated STAT3 in Human Breast and Lung Cancer Cells by Manuka Honey is Mediated by Selective Antagonism of the IL-6 Receptor. Int. J. Mol. Sci. 2019, 20(18), 4340.
   PubMed Web of Science ®Google Scholar
• Hong, T. B.; Rahumatullah, A.; Yogarajah, T.; Ahmad, M.; Yin, K. B. Potential effects of chrysin on MDA-MB-231 cells. Int. J. Mol. Sci. 2010, 11(3), 1057–1069. DOI: 10.3390/ijms11031057.
   PubMed Web of Science ®Google Scholar
• Sun, L. P.; Chen, A. L.; Hung, H. C.; Chien, Y. H.; Huang, J. S.; Huang, C. Y.; Chen, Y. W.; Chen, C. N. Chrysin: a histone deacetylase 8 inhibitor with anticancer activity and a suitable candidate for the standardization of Chinese propolis. J. Agric. Food Chem. 2012, 60(47), 11748–11758. DOI: 10.1021/jf303261r.
   PubMed Web of Science ®Google Scholar
• Eatemadi, A.; Daraee, H.; Aiyelabegan, H. T.; Negahdari, B.; Rajeian, B.; Zarghami, N. Synthesis and Characterization of Chrysin-loaded PCL-PEG-PCL nanoparticle and its effect on breast cancer cell line. Biomed. Pharmacother. 2016, 84, 1915–1922. DOI: 10.1016/j.biopha.2016.10.095.
   PubMed Web of Science ®Google Scholar
• Hong, J.; Fristiohady, A.; Nguyen, C. H.; Milovanovic, D.; Huttary, N.; Krieger, S.; Hong, J.; Geleff, S.; Birner, P.; Jager, W., et al. Apigenin and Luteolin Attenuate the Breaching of MDA-MB231 Breast Cancer Spheroids Through the Lymph Endothelial Barrier in Vitro. Front. Pharmacol. 2018, 9, 220. DOI: 10.3389/fphar.2018.00220.
   PubMed Web of Science ®Google Scholar
• Li, F.; Ye, L.; Lin, S. M.; Leung, L. K. Dietary flavones and flavonones display differential effects on aromatase (CYP19) transcription in the breast cancer cells MCF-7. Mol. Cell. Endocrinol. 2011, 344(1–2), 51–58. DOI: 10.1016/j.mce.2011.06.024.
   PubMed Web of Science ®Google Scholar
• Jin, X. Y.; Ren, C. S. [Effect and mechanism of apigenin on VEGF expression in human breast cancer cells]. Zhonghua Zhong Liu Za Zhi. 2007, 29(7), 495–499.
   PubMedGoogle Scholar
• Choi, E. J.; Kim, G. H. Apigenin causes G(2)/M arrest associated with the modulation of p21(Cip1) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells. J. Nutr. Biochem. 2009, 20(4), 285–290. DOI: 10.1016/j.jnutbio.2008.03.005.
   PubMed Web of Science ®Google Scholar
• Scherbakov, A. M.; Shestakova, E. A.; Galeeva, K. E.; Bogush, T. A. [BRCA1 and Estrogen Receptor alpha Expression Regulation in Breast Cancer Cells]. Mol Biol (Mosk). 2019, 53(3), 502–512. DOI: 10.1134/S0026893319030166.
   PubMed Web of Science ®Google Scholar
• Schindler, R.; Mentlein, R. Flavonoids and vitamin E reduce the release of the angiogenic peptide vascular endothelial growth factor from human tumor cells. J. Nutr. 2006, 136(6), 1477–1482. DOI: 10.1093/jn/136.6.1477.
   PubMed Web of Science ®Google Scholar
• Sigismund, S.; Avanzato, D.; Lanzetti, L. Emerging functions of the EGFR in cancer. Mol. Oncol. 2018, 12(1), 3–20. DOI: 10.1002/1878-0261.12155.
   PubMed Web of Science ®Google Scholar
• Changavi, A. A.; Shashikala, A.; Ramji, A. S. Epidermal Growth Factor Receptor Expression in Triple Negative and Nontriple Negative Breast Carcinomas. J. Lab. Physicians. 2015, 7(2), 79–83. DOI: 10.4103/0974-2727.163129.
   PubMedGoogle Scholar
• Shostak, K.; Chariot, A. EGFR and NF-kappaB: partners in cancer. Trends Mol. Med. 2015, 21(6), 385–393. DOI: 10.1016/j.molmed.2015.04.001.
   PubMed Web of Science ®Google Scholar
• Huang, Q.; Li, S.; Zhang, L.; Qiao, X.; Zhang, Y.; Zhao, X.; Xiao, G.; Li, Z. CAPE-pNO2 Inhibited the Growth and Metastasis of Triple-Negative Breast Cancer via the EGFR/STAT3/Akt/E-Cadherin Signaling Pathway. Front. Oncol. 2019, 9, 461. DOI: 10.3389/fonc.2019.00461.
   PubMed Web of Science ®Google Scholar
• Shi, Y.; Qin, N.; Zhou, Q.; Chen, Y.; Huang, S.; Chen, B.; Shen, G.; Jia, H. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma. J. Transl. Med. 2017, 15(1), 176. DOI: 10.1186/s12967-017-1275-8.
   PubMed Web of Science ®Google Scholar
• Kumar, D.; Hassan, M. K.; Pattnaik, N.; Mohapatra, N.; Dixit, M.; Coleman, W. B. Reduced expression of IQGAP2 and higher expression of IQGAP3 correlates with poor prognosis in cancers. PloS one. 2017, 12(10), e0186977. DOI: 10.1371/journal.pone.0186977.
   PubMed Web of Science ®Google Scholar
• Lee, G. A.; Choi, K. C.; Hwang, K. A. Kaempferol, a phytoestrogen, suppressed triclosan-induced epithelial-mesenchymal transition and metastatic-related behaviors of MCF-7 breast cancer cells. Environ. Toxicol. Pharmacol. 2017, 49, 48–57. DOI: 10.1016/j.etap.2016.11.016.
   PubMed Web of Science ®Google Scholar
• Kim, S. H.; Hwang, K. A.; Choi, K. C. Treatment with kaempferol suppresses breast cancer cell growth caused by estrogen and triclosan in cellular and xenograft breast cancer models. J. Nutr. Biochem. 2016, 28, 70–82. DOI: 10.1016/j.jnutbio.2015.09.027.
   PubMed Web of Science ®Google Scholar
• Pang, X.; Fu, W.; Wang, J.; Kang,; Xu, L.; Zhao, Y.; Liu, A.-L.; Du, A. L.; Kang, G. H. Identification of Estrogen Receptor alpha Antagonists from Natural Products via In Vitro and In Silico Approaches. Oxid. Med. Cell. Longev. 2018, 2018, 6040149. DOI: 10.1155/2018/6040149.
   PubMed Web of Science ®Google Scholar
• Resende, F. A.; de Oliveira, A. P.; de Camargo, M. S.; Vilegas, W.; Varanda, E. A.; Jeong, J.-W. Evaluation of estrogenic potential of flavonoids using a recombinant yeast strain and MCF7/BUS cell proliferation assay. PloS one. 2013, 8(10), e74881. DOI: 10.1371/journal.pone.0074881.
   PubMed Web of Science ®Google Scholar
• Oh, S. M.; Kim, Y. P.; Chung, K. H. Biphasic effects of kaempferol on the estrogenicity in human breast cancer cells. Arch. Pharm. Res. 2006, 29(5), 354–362. DOI: 10.1007/BF02968584.
   PubMed Web of Science ®Google Scholar
• Harris, D. M.; Besselink, E.; Henning, S. M.; Go, V. L.; Heber, D. Phytoestrogens induce differential estrogen receptor alpha- or Beta-mediated responses in transfected breast cancer cells. Exp. Biol. Med. (Maywood). 2005, 230(8), 558–568. DOI: 10.1177/153537020523000807.
   PubMed Web of Science ®Google Scholar
• Shahi Thakuri, P.; Gupta, M.; Singh, S.; Joshi, R.; Glasgow, E.; Lekan, A.; Agarwal, S.; Luker, G. D.; Tavana, H. Phytochemicals inhibit migration of triple negative breast cancer cells by targeting kinase signaling. BMC cancer. 2020, 20(1), 4. DOI: 10.1186/s12885-019-6479-2.
   PubMed Web of Science ®Google Scholar
• Song, N. R.; Chung, M. Y.; Kang, N. J.; Seo, S. G.; Jang, T. S.; Lee, H. J.; Lee, K. W. Quercetin suppresses invasion and migration of H-Ras-transformed MCF10A human epithelial cells by inhibiting phosphatidylinositol 3-kinase. Food Chem. 2014, 142, 66–71. DOI: 10.1016/j.foodchem.2013.07.002.
   PubMed Web of Science ®Google Scholar
• Moreira, L.; Araujo, I.; Costa, T.; Correia-Branco, A.; Faria, A.; Martel, F.; Keating, E. Quercetin and epigallocatechin gallate inhibit glucose uptake and metabolism by breast cancer cells by an estrogen receptor-independent mechanism. Exp. Cell Res. 2013, 319(12), 1784–1795. DOI: 10.1016/j.yexcr.2013.05.001.
   PubMed Web of Science ®Google Scholar
• Zhao, X.; Wang, Q.; Yang, S.; Chen, C.; Li, X.; Liu, J.; Zou, Z.; Cai, D. Quercetin inhibits angiogenesis by targeting calcineurin in the xenograft model of human breast cancer. Eur. J. Pharmacol. 2016, 781, 60–68. DOI: 10.1016/j.ejphar.2016.03.063.
   PubMed Web of Science ®Google Scholar
• Zhu, L.; Luo, Q.; Bi, J.; Ding, J.; Ge, S.; Chen, F. Galangin inhibits growth of human head and neck squamous carcinoma cells in vitro and in vivo. Chem.-Biol. Interact. 2014, 224, 149–156. DOI: 10.1016/j.cbi.2014.10.027.
   PubMed Web of Science ®Google Scholar
• Tolomeo, M.; Grimaudo, S.; Di Cristina, A.; Pipitone, R. M.; Dusonchet, L.; Meli, M.; Crosta, L.; Gebbia, N.; Invidiata, F. P.; Titone, L. Galangin increases the cytotoxic activity of imatinib mesylate in imatinib-sensitive and imatinib-resistant Bcr-Abl expressing leukemia cells. Cancer Lett. 2008, 265(2), 289–297. DOI: 10.1016/j.canlet.2008.02.025.
   PubMed Web of Science ®Google Scholar
• Sulaiman, G. Molecular structure and antiproliferative effect of galangin in HCT116 cells. vitro. 2016.
   Google Scholar
• Cook, M. T.; Liang, Y.; Besch-Williford, C.; Hyder, S. M. Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cells. Breast Cancer (Dove Med Press). 2017, 9, 9–19. DOI: 10.2147/BCTT.S124860.
   PubMed Web of Science ®Google Scholar
• Cook, M. T.; Mafuvadze, B.; Besch-Williford, C.; Ellersieck, M. R.; Goyette, S.; Hyder, S. M. Luteolin suppresses development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats. Oncol. Rep. 2016, 35(2), 825–832. DOI: 10.3892/or.2015.4431.
   PubMed Web of Science ®Google Scholar
• Cook, M. T.; Liang, Y.; Besch-Williford, C.; Goyette, S.; Mafuvadze, B.; Hyder, S. M. Luteolin inhibits progestin-dependent angiogenesis, stem cell-like characteristics, and growth of human breast cancer xenografts. Springerplus. 2015, 4(1), 444. DOI: 10.1186/s40064-015-1242-x.
   PubMedGoogle Scholar
• Seo, H. S.; Choi, H. S.; Kim, S. R.; Choi, Y. K.; Woo, S. M.; Shin, I.; Woo, J. K.; Park, S. Y.; Shin, Y. C.; Ko, S. G. Apigenin induces apoptosis via extrinsic pathway, inducing p53 and inhibiting STAT3 and NFkappaB signaling in HER2-overexpressing breast cancer cells. Mol. Cell. Biochem. 2012, 366(1–2), 319–334. DOI: 10.1007/s11010-012-1310-2.
   PubMed Web of Science ®Google Scholar
• Mafuvadze, B.; Liang, Y.; Besch-Williford, C.; Zhang, X.; Hyder, S. M. Apigenin induces apoptosis and blocks growth of medroxyprogesterone acetate-dependent BT-474 xenograft tumors. Hormones Cancer. 2012, 3(4), 160–171. DOI: 10.1007/s12672-012-0114-x.
   PubMed Web of Science ®Google Scholar
• Mafuvadze, B.; Benakanakere, I.; Lopez Perez, F. R.; Besch-Williford, C.; Ellersieck, M. R.; Hyder, S. M. Apigenin prevents development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats. Cancer Prev. Res. (Phila). 2011, 4(8), 1316–1324. DOI: 10.1158/1940-6207.CAPR-10-0382.
   PubMed Web of Science ®Google Scholar
• Ristivojevic, P.; Trifkovic, J.; Andric, F.; Milojkovic-Opsenica, D. Poplar-type Propolis: Chemical Composition, Botanical Origin and Biological Activity. Nat. Prod. Commun. 2015, 10(11), 1869–1876.
   PubMed Web of Science ®Google Scholar
• Diaz-Carballo, D.; Malak, S.; Bardenheuer, W.; Freistuehler, M.; Reusch, H. P. Cytotoxic activity of nemorosone in neuroblastoma cells. J. Cellular Mol. Med. 2008, 12(6B), 2598–2608. DOI: 10.1111/j.1582-4934.2008.00232.x.
   PubMed Web of Science ®Google Scholar
• Camargo, M. S.; Prieto, A. M.; Resende, F. A.; Boldrin, P. K.; Cardoso, C. R.; Fernandez, M. F.; Molina-Molina, J. M.; Olea, N.; Vilegas, W.; Cuesta-Rubio, O., et al. Evaluation of estrogenic, antiestrogenic and genotoxic activity of nemorosone, the major compound found in brown Cuban propolis. BMC Complement. Altern. Med. 2013, 13(1), 201.
   PubMed Web of Science ®Google Scholar
• Camargo, M. S.; Varela, S. D.; de Oliveira, A. P. S.; Resende, F. A.; Cuesta-Rubio, O.; Vilegas, W.; Varanda, E. A. Assessment of estrogenic, mutagenic and antimutagenic activity of nemorosone. Brazilian J. Pharmacognosy. 2011, 21(5), 921–927. DOI: 10.1590/S0102-695X2011005000148.
   Google Scholar
• Braakhuis, A. Evidence on the health benefits of supplemental propolis. Nutrients. 2019, 11(11), 2705.
   PubMed Web of Science ®Google Scholar
• Yesiltas, B.; Capanoglu, E.; Firatligil-Durmus, E.; Sunay, A. E.; Samanci, T.; Boyacioglu, D. Investigating the in-vitro bioaccessibility of propolis and pollen using a simulated gastrointestinal digestion System. J. Apic. Res. 2014, 53(1), 101–108. DOI: 10.3896/IBRA.1.53.1.10.
   Web of Science ®Google Scholar
• Curti, V.; Zaccaria, V.; Tsetegho Sokeng, A. J.; Dacrema, M.; Masiello, I.; Mascaro, A.; D’Antona, G.; Daglia, M. Bioavailability and in vivo antioxidant activity of a standardized polyphenol mixture extracted from brown propolis. Int. J. Mol. Sci. 2019, 20(5), 1250. DOI: 10.3390/ijms20051250.
   PubMed Web of Science ®Google Scholar
• Boufadi, Y. M.; Van Antwerpen, P.; Chikh Alard, I.; Nève, J.; Djennas, N.; Riazi, A.; Soubhye, J. Antioxidant effects and bioavailability evaluation of propolis extract and its content of pure polyphenols. J. Food Biochem. 2018, 42(1), e12434. DOI: 10.1111/jfbc.12434.
   Web of Science ®Google Scholar
• Mesbah, L.; Samia, A Bioavailability and pharmacokinetic of the Algerian propolis constituent naringenin in rats after oral administration. Planta Med. 2011, 77(12), PA11. DOI: 10.1055/s-0031-1282207.
   Web of Science ®Google Scholar
• Kubiliene, L.; Jekabsone, A.; Zilius, M.; Trumbeckaite, S.; Simanaviciute, D.; Gerbutaviciene, R.; Majiene, D. Comparison of aqueous, polyethylene glycol-aqueous and ethanolic propolis extracts: antioxidant and mitochondria modulating properties. BMC Complementary Altern. Med. 2018, 18(1), 1–10. DOI: 10.1186/s12906-018-2234-5.
   PubMedGoogle Scholar
• Woźniak, M.; Mrówczyńska, L.; Kwaśniewska-Sip, P.; Waśkiewicz, A.; Nowak, P.; Ratajczak, I. Effect of the solvent on propolis phenolic profile and its antifungal, antioxidant, and in vitro cytoprotective activity in human erythrocytes under oxidative stress. Molecules. 2020, 25(18), 4266. DOI: 10.3390/molecules25184266.
   PubMed Web of Science ®Google Scholar
• Mendez-Pfeiffer, P.; Juarez, J.; Hernández, J.; Taboada, P.; Virues, C.; Valencia, D.; Velazquez, C. Nanocarriers as drug delivery systems for propolis: A therapeutic approach. J. Drug Delivery Sci. Technol. 2021, 65, 102762. DOI: 10.1016/j.jddst.2021.102762.
   Web of Science ®Google Scholar
• Huang, C.; Wei, Y. X.; Shen, M. C.; Tu, Y. H.; Wang, C. C.; Huang, H. C. Chrysin, Abundant in Morinda citrifolia Fruit Water-EtOAc Extracts, Combined with Apigenin Synergistically Induced Apoptosis and Inhibited Migration in Human Breast and Liver Cancer Cells. J. Agric. Food Chem. 2016, 64(21), 4235–4245. DOI: 10.1021/acs.jafc.6b00766.
   PubMed Web of Science ®Google Scholar
• Ackland, M. L.; van de Waarsenburg, S.; Jones, R. Synergistic antiproliferative action of the flavonols quercetin and kaempferol in cultured human cancer cell lines. Vivo. 2005, 19(1), 69–76.
   PubMed Web of Science ®Google Scholar
• Huang, C.; Huang, Y. L.; Wang, C. C.; Pan, Y. L.; Lai, Y. H.; Huang, H. C. Ampelopsins A and C Induce Apoptosis and Metastasis through Downregulating AxL, TYRO3, and FYN Expressions in MDA-MB-231 Breast Cancer Cells. J. Agric. Food Chem. 2019, 67(10), 2818–2830. DOI: 10.1021/acs.jafc.8b06444.
   PubMed Web of Science ®Google Scholar
• Yang, M. Y.; Wang, C. J.; Chen, N. F.; Ho, W. H.; Lu, F. J.; Tseng, T. H. Luteolin enhances paclitaxel-induced apoptosis in human breast cancer MDA-MB-231 cells by blocking STAT3. Chem. Biol. Interact. 2014, 213, 60–68. DOI: 10.1016/j.cbi.2014.02.002.
   PubMed Web of Science ®Google Scholar
• Choi, E. J.; Kim, G. H. 5-Fluorouracil combined with apigenin enhances anticancer activity through induction of apoptosis in human breast cancer MDA-MB-453 cells. Oncol. Rep. 2009, 22(6), 1533–1537. DOI: 10.3892/or_00000598.
   PubMed Web of Science ®Google Scholar
• Samy, R. P.; Gopalakrishnakone, P.; Ignacimuthu, S. Anti-tumor promoting potential of luteolin against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats. Chem. Biol. Interact. 2006, 164(1–2), 1–14. DOI: 10.1016/j.cbi.2006.08.018.
   PubMed Web of Science ®Google Scholar
• Scambia, G.; Ranelletti, F. O.; Panici, P. B.; De Vincenzo, R.; Bonanno, G.; Ferrandina, G.; Piantelli, M.; Bussa, S.; Rumi, C.; Cianfriglia, M., et al. Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target. Cancer Chemother. Pharmacol. 1994, 34(6), 459–464.
   PubMed Web of Science ®Google Scholar
• Ozkan, E.; Bakar-Ates, F. Potentiation of the Effect of Lonidamine by Quercetin in MCF-7 human breast cancer cells through downregulation of MMP-2/9 mRNA Expression. Anais da Academia Brasileira de Ciencias. 2020, 92(4), e20200548. DOI: 10.1590/0001-3765202020200548.
   PubMed Web of Science ®Google Scholar
• Li, J.; Zhang, J.; Wang, Y.; Liang, X.; Wusiman, Z.; Yin, Y.; Shen, Q. Synergistic inhibition of migration and invasion of breast cancer cells by dual docetaxel/quercetin-loaded nanoparticles via Akt/MMP-9 pathway. Int. J. Pharm. 2017, 523(1), 300–309. DOI: 10.1016/j.ijpharm.2017.03.040.
   PubMed Web of Science ®Google Scholar
• Gyemant, N.; Tanaka, M.; Antus, S.; Hohmann, J.; Csuka, O.; Mandoky, L.; Molnar, J. In vitro search for synergy between flavonoids and epirubicin on multidrug-resistant cancer cells. Vivo. 2005, 19(2), 367–374.
   PubMed Web of Science ®Google Scholar